US9949915B2 - Non-comedogenic and non-acnegenic hair and scalp care formulations and method for use - Google Patents
Non-comedogenic and non-acnegenic hair and scalp care formulations and method for use Download PDFInfo
- Publication number
- US9949915B2 US9949915B2 US15/618,420 US201715618420A US9949915B2 US 9949915 B2 US9949915 B2 US 9949915B2 US 201715618420 A US201715618420 A US 201715618420A US 9949915 B2 US9949915 B2 US 9949915B2
- Authority
- US
- United States
- Prior art keywords
- amount
- present
- composition
- hair
- comedogenic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 125
- 210000004209 hair Anatomy 0.000 title claims abstract description 101
- 210000004761 scalp Anatomy 0.000 title claims abstract description 7
- 238000000034 method Methods 0.000 title claims description 18
- 238000009472 formulation Methods 0.000 title description 53
- 230000002333 acnegenic effect Effects 0.000 title description 22
- 238000011282 treatment Methods 0.000 claims abstract description 8
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 27
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 20
- 210000002374 sebum Anatomy 0.000 claims description 17
- 239000002453 shampoo Substances 0.000 claims description 16
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 16
- 239000003205 fragrance Substances 0.000 claims description 14
- 239000003109 Disodium ethylene diamine tetraacetate Substances 0.000 claims description 13
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 claims description 13
- 235000019301 disodium ethylene diamine tetraacetate Nutrition 0.000 claims description 13
- 239000003921 oil Substances 0.000 claims description 13
- 239000003795 chemical substances by application Substances 0.000 claims description 12
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 claims description 11
- 229960005323 phenoxyethanol Drugs 0.000 claims description 11
- 235000011187 glycerol Nutrition 0.000 claims description 10
- WTVHAMTYZJGJLJ-UHFFFAOYSA-N (+)-(4S,8R)-8-epi-beta-bisabolol Natural products CC(C)=CCCC(C)C1(O)CCC(C)=CC1 WTVHAMTYZJGJLJ-UHFFFAOYSA-N 0.000 claims description 9
- RGZSQWQPBWRIAQ-CABCVRRESA-N (-)-alpha-Bisabolol Chemical compound CC(C)=CCC[C@](C)(O)[C@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-CABCVRRESA-N 0.000 claims description 9
- NCZPCONIKBICGS-UHFFFAOYSA-N 3-(2-ethylhexoxy)propane-1,2-diol Chemical compound CCCCC(CC)COCC(O)CO NCZPCONIKBICGS-UHFFFAOYSA-N 0.000 claims description 9
- RGZSQWQPBWRIAQ-LSDHHAIUSA-N alpha-Bisabolol Natural products CC(C)=CCC[C@@](C)(O)[C@@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-LSDHHAIUSA-N 0.000 claims description 9
- 229940036350 bisabolol Drugs 0.000 claims description 9
- HHGZABIIYIWLGA-UHFFFAOYSA-N bisabolol Natural products CC1CCC(C(C)(O)CCC=C(C)C)CC1 HHGZABIIYIWLGA-UHFFFAOYSA-N 0.000 claims description 9
- 229940100524 ethylhexylglycerin Drugs 0.000 claims description 9
- 150000001335 aliphatic alkanes Chemical class 0.000 claims description 8
- 230000003750 conditioning effect Effects 0.000 claims description 8
- 229940081733 cetearyl alcohol Drugs 0.000 claims description 7
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 claims description 7
- 230000001530 keratinolytic effect Effects 0.000 claims description 6
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 claims description 6
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 claims description 6
- 229940068968 polysorbate 80 Drugs 0.000 claims description 6
- 229920000053 polysorbate 80 Polymers 0.000 claims description 6
- 235000018936 Vitellaria paradoxa Nutrition 0.000 claims description 5
- 241001135917 Vitellaria paradoxa Species 0.000 claims description 5
- 239000002260 anti-inflammatory agent Substances 0.000 claims description 5
- 229940121363 anti-inflammatory agent Drugs 0.000 claims description 5
- 229920001577 copolymer Polymers 0.000 claims description 5
- 229940049292 n-(3-(dimethylamino)propyl)octadecanamide Drugs 0.000 claims description 5
- WWVIUVHFPSALDO-UHFFFAOYSA-N n-[3-(dimethylamino)propyl]octadecanamide Chemical compound CCCCCCCCCCCCCCCCCC(=O)NCCCN(C)C WWVIUVHFPSALDO-UHFFFAOYSA-N 0.000 claims description 5
- 125000000913 palmityl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 5
- 229940057910 shea butter Drugs 0.000 claims description 5
- FLPJVCMIKUWSDR-UHFFFAOYSA-N 2-(4-formylphenoxy)acetamide Chemical compound NC(=O)COC1=CC=C(C=O)C=C1 FLPJVCMIKUWSDR-UHFFFAOYSA-N 0.000 claims description 3
- OYINQIKIQCNQOX-UHFFFAOYSA-M 2-hydroxybutyl(trimethyl)azanium;chloride Chemical compound [Cl-].CCC(O)C[N+](C)(C)C OYINQIKIQCNQOX-UHFFFAOYSA-M 0.000 claims description 3
- 244000007835 Cyamopsis tetragonoloba Species 0.000 claims description 3
- CBTVGIZVANVGBH-UHFFFAOYSA-N aminomethyl propanol Chemical compound CC(C)(N)CO CBTVGIZVANVGBH-UHFFFAOYSA-N 0.000 claims description 3
- 239000004599 antimicrobial Substances 0.000 claims description 3
- 229940074979 cetyl palmitate Drugs 0.000 claims description 3
- 229940031728 cocamidopropylamine oxide Drugs 0.000 claims description 3
- PXDJXZJSCPSGGI-UHFFFAOYSA-N hexadecanoic acid hexadecyl ester Natural products CCCCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCCCC PXDJXZJSCPSGGI-UHFFFAOYSA-N 0.000 claims description 3
- 229940007636 sodium lauroyl methyl isethionate Drugs 0.000 claims description 3
- NVIZQHFCDBQNPH-UHFFFAOYSA-M sodium;2-dodecanoyloxypropane-1-sulfonate Chemical compound [Na+].CCCCCCCCCCCC(=O)OC(C)CS([O-])(=O)=O NVIZQHFCDBQNPH-UHFFFAOYSA-M 0.000 claims description 3
- FPVVYTCTZKCSOJ-UHFFFAOYSA-N Ethylene glycol distearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCOC(=O)CCCCCCCCCCCCCCCCC FPVVYTCTZKCSOJ-UHFFFAOYSA-N 0.000 claims description 2
- 229940100608 glycol distearate Drugs 0.000 claims description 2
- 239000002973 irritant agent Substances 0.000 claims description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 claims 2
- UHUSDOQQWJGJQS-UHFFFAOYSA-N glycerol 1,2-dioctadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(CO)OC(=O)CCCCCCCCCCCCCCCCC UHUSDOQQWJGJQS-UHFFFAOYSA-N 0.000 claims 2
- 235000015165 citric acid Nutrition 0.000 claims 1
- 239000002085 irritant Substances 0.000 claims 1
- 231100000021 irritant Toxicity 0.000 claims 1
- 150000003467 sulfuric acid derivatives Chemical class 0.000 claims 1
- 206010000496 acne Diseases 0.000 description 56
- 239000004615 ingredient Substances 0.000 description 45
- 208000002874 Acne Vulgaris Diseases 0.000 description 43
- 210000003491 skin Anatomy 0.000 description 33
- 238000002156 mixing Methods 0.000 description 16
- 235000019198 oils Nutrition 0.000 description 12
- 239000006071 cream Substances 0.000 description 9
- 239000000463 material Substances 0.000 description 9
- 229920001296 polysiloxane Polymers 0.000 description 9
- 230000004054 inflammatory process Effects 0.000 description 8
- 230000007794 irritation Effects 0.000 description 8
- 238000004519 manufacturing process Methods 0.000 description 8
- 239000011148 porous material Substances 0.000 description 8
- 239000000126 substance Substances 0.000 description 8
- 206010061218 Inflammation Diseases 0.000 description 7
- 210000003780 hair follicle Anatomy 0.000 description 7
- -1 DMAPA acrylates Chemical class 0.000 description 6
- 239000000654 additive Substances 0.000 description 6
- 230000008901 benefit Effects 0.000 description 6
- 238000011012 sanitization Methods 0.000 description 6
- 238000009499 grossing Methods 0.000 description 5
- 235000019388 lanolin Nutrition 0.000 description 5
- 206010000502 Acne cosmetica Diseases 0.000 description 4
- 206010016936 Folliculitis Diseases 0.000 description 4
- 239000004166 Lanolin Substances 0.000 description 4
- 206010033733 Papule Diseases 0.000 description 4
- 239000000499 gel Substances 0.000 description 4
- 230000005484 gravity Effects 0.000 description 4
- 230000002757 inflammatory effect Effects 0.000 description 4
- 229940039717 lanolin Drugs 0.000 description 4
- 230000003902 lesion Effects 0.000 description 4
- 244000052769 pathogen Species 0.000 description 4
- 239000007921 spray Substances 0.000 description 4
- 230000000699 topical effect Effects 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 3
- 244000276331 Citrus maxima Species 0.000 description 3
- 235000001759 Citrus maxima Nutrition 0.000 description 3
- 241000186427 Cutibacterium acnes Species 0.000 description 3
- 244000179886 Moringa oleifera Species 0.000 description 3
- 235000011347 Moringa oleifera Nutrition 0.000 description 3
- 206010054107 Nodule Diseases 0.000 description 3
- OQILCOQZDHPEAZ-UHFFFAOYSA-N Palmitinsaeure-octylester Natural products CCCCCCCCCCCCCCCC(=O)OCCCCCCCC OQILCOQZDHPEAZ-UHFFFAOYSA-N 0.000 description 3
- 108010084695 Pea Proteins Proteins 0.000 description 3
- 230000001580 bacterial effect Effects 0.000 description 3
- YSJGOMATDFSEED-UHFFFAOYSA-M behentrimonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCCCCCC[N+](C)(C)C YSJGOMATDFSEED-UHFFFAOYSA-M 0.000 description 3
- 229940075506 behentrimonium chloride Drugs 0.000 description 3
- 239000002537 cosmetic Substances 0.000 description 3
- 208000031513 cyst Diseases 0.000 description 3
- SFNALCNOMXIBKG-UHFFFAOYSA-N ethylene glycol monododecyl ether Chemical compound CCCCCCCCCCCCOCCO SFNALCNOMXIBKG-UHFFFAOYSA-N 0.000 description 3
- 230000003325 follicular Effects 0.000 description 3
- 229940107702 grapefruit seed extract Drugs 0.000 description 3
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 3
- 235000019702 pea protein Nutrition 0.000 description 3
- 230000028327 secretion Effects 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 239000004094 surface-active agent Substances 0.000 description 3
- 230000009885 systemic effect Effects 0.000 description 3
- 239000001993 wax Substances 0.000 description 3
- YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 description 2
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 2
- 208000002782 Acneiform Eruptions Diseases 0.000 description 2
- 241001340526 Chrysoclista linneella Species 0.000 description 2
- 201000004624 Dermatitis Diseases 0.000 description 2
- 244000148064 Enicostema verticillatum Species 0.000 description 2
- 229920002884 Laureth 4 Polymers 0.000 description 2
- 206010027626 Milia Diseases 0.000 description 2
- 239000004264 Petrolatum Substances 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- 206010040880 Skin irritation Diseases 0.000 description 2
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 2
- BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- 208000009736 adult acne Diseases 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 230000001332 colony forming effect Effects 0.000 description 2
- 230000002596 correlated effect Effects 0.000 description 2
- 239000008367 deionised water Substances 0.000 description 2
- 229910021641 deionized water Inorganic materials 0.000 description 2
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N dodecahydrosqualene Natural products CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 2
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 2
- 230000002538 fungal effect Effects 0.000 description 2
- 239000008266 hair spray Substances 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 229940061515 laureth-4 Drugs 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 230000009965 odorless effect Effects 0.000 description 2
- LSTDYDRCKUBPDI-UHFFFAOYSA-N palmityl acetate Chemical compound CCCCCCCCCCCCCCCCOC(C)=O LSTDYDRCKUBPDI-UHFFFAOYSA-N 0.000 description 2
- 230000035515 penetration Effects 0.000 description 2
- 235000019271 petrolatum Nutrition 0.000 description 2
- 229940066842 petrolatum Drugs 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 210000001732 sebaceous gland Anatomy 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 230000036556 skin irritation Effects 0.000 description 2
- 231100000475 skin irritation Toxicity 0.000 description 2
- 239000000344 soap Substances 0.000 description 2
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 2
- 229940031439 squalene Drugs 0.000 description 2
- TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 description 2
- ALSTYHKOOCGGFT-KTKRTIGZSA-N (9Z)-octadecen-1-ol Chemical compound CCCCCCCC\C=C/CCCCCCCCO ALSTYHKOOCGGFT-KTKRTIGZSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- QMMJWQMCMRUYTG-UHFFFAOYSA-N 1,2,4,5-tetrachloro-3-(trifluoromethyl)benzene Chemical compound FC(F)(F)C1=C(Cl)C(Cl)=CC(Cl)=C1Cl QMMJWQMCMRUYTG-UHFFFAOYSA-N 0.000 description 1
- LGEZTMRIZWCDLW-UHFFFAOYSA-N 14-methylpentadecyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCCCCCCCCCCCCC(C)C LGEZTMRIZWCDLW-UHFFFAOYSA-N 0.000 description 1
- ABEXEQSGABRUHS-UHFFFAOYSA-N 16-methylheptadecyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCCCC(C)C ABEXEQSGABRUHS-UHFFFAOYSA-N 0.000 description 1
- JSOVGYMVTPPEND-UHFFFAOYSA-N 16-methylheptadecyl 2,2-dimethylpropanoate Chemical compound CC(C)CCCCCCCCCCCCCCCOC(=O)C(C)(C)C JSOVGYMVTPPEND-UHFFFAOYSA-N 0.000 description 1
- FKOKUHFZNIUSLW-UHFFFAOYSA-N 2-Hydroxypropyl stearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(C)O FKOKUHFZNIUSLW-UHFFFAOYSA-N 0.000 description 1
- KGULFLCOPRYBEV-KTKRTIGZSA-N 2-[2-[2-[(z)-octadec-9-enoxy]ethoxy]ethoxy]ethanol Chemical compound CCCCCCCC\C=C/CCCCCCCCOCCOCCOCCO KGULFLCOPRYBEV-KTKRTIGZSA-N 0.000 description 1
- RFVNOJDQRGSOEL-UHFFFAOYSA-N 2-hydroxyethyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCO RFVNOJDQRGSOEL-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- ZGIGZINMAOQWLX-NCZFFCEISA-N 3,7,11-Trimethyl-2,6,10-dodecatrienyl acetate Chemical compound CC(C)=CCC\C(C)=C\CC\C(C)=C\COC(C)=O ZGIGZINMAOQWLX-NCZFFCEISA-N 0.000 description 1
- IFYVAPPYWOMVDP-ZDUSSCGKSA-N 3-[[(2r)-2,4-diacetyloxy-3,3-dimethylbutanoyl]amino]propyl acetate Chemical compound CC(=O)OCCCNC(=O)[C@H](OC(C)=O)C(C)(C)COC(C)=O IFYVAPPYWOMVDP-ZDUSSCGKSA-N 0.000 description 1
- ODMZDMMTKHXXKA-QXMHVHEDSA-N 8-methylnonyl (z)-octadec-9-enoate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCCCCCCCC(C)C ODMZDMMTKHXXKA-QXMHVHEDSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 208000020154 Acnes Diseases 0.000 description 1
- 235000019489 Almond oil Nutrition 0.000 description 1
- 208000019901 Anxiety disease Diseases 0.000 description 1
- LFYJSSARVMHQJB-UHFFFAOYSA-N Backuchiol Natural products CC(C)=CCCC(C)(C=C)C=CC1=CC=C(O)C=C1 LFYJSSARVMHQJB-UHFFFAOYSA-N 0.000 description 1
- 240000008886 Ceratonia siliqua Species 0.000 description 1
- 235000013912 Ceratonia siliqua Nutrition 0.000 description 1
- 240000003538 Chamaemelum nobile Species 0.000 description 1
- 235000007866 Chamaemelum nobile Nutrition 0.000 description 1
- 208000032544 Cicatrix Diseases 0.000 description 1
- 241000195493 Cryptophyta Species 0.000 description 1
- 244000303965 Cyamopsis psoralioides Species 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 description 1
- XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 description 1
- 241000721098 Epilobium Species 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- ZGIGZINMAOQWLX-UHFFFAOYSA-N Farnesyl acetate Natural products CC(C)=CCCC(C)=CCCC(C)=CCOC(C)=O ZGIGZINMAOQWLX-UHFFFAOYSA-N 0.000 description 1
- 235000017367 Guainella Nutrition 0.000 description 1
- 206010019049 Hair texture abnormal Diseases 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical group Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- SHGAZHPCJJPHSC-NUEINMDLSA-N Isotretinoin Chemical compound OC(=O)C=C(C)/C=C/C=C(C)C=CC1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-NUEINMDLSA-N 0.000 description 1
- 102000011782 Keratins Human genes 0.000 description 1
- 108010076876 Keratins Proteins 0.000 description 1
- 241001598113 Laminaria digitata Species 0.000 description 1
- 239000005639 Lauric acid Substances 0.000 description 1
- 235000007232 Matricaria chamomilla Nutrition 0.000 description 1
- 241000772415 Neovison vison Species 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 208000012868 Overgrowth Diseases 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 206010037888 Rash pustular Diseases 0.000 description 1
- 240000001890 Ribes hudsonianum Species 0.000 description 1
- 235000016954 Ribes hudsonianum Nutrition 0.000 description 1
- 235000001466 Ribes nigrum Nutrition 0.000 description 1
- 240000007651 Rubus glaucus Species 0.000 description 1
- 235000011034 Rubus glaucus Nutrition 0.000 description 1
- 235000009122 Rubus idaeus Nutrition 0.000 description 1
- NGFMICBWJRZIBI-JZRPKSSGSA-N Salicin Natural products O([C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@H](CO)O1)c1c(CO)cccc1 NGFMICBWJRZIBI-JZRPKSSGSA-N 0.000 description 1
- 206010039792 Seborrhoea Diseases 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- NWGKJDSIEKMTRX-AAZCQSIUSA-N Sorbitan monooleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O NWGKJDSIEKMTRX-AAZCQSIUSA-N 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- FHNINJWBTRXEBC-UHFFFAOYSA-N Sudan III Chemical compound OC1=CC=C2C=CC=CC2=C1N=NC(C=C1)=CC=C1N=NC1=CC=CC=C1 FHNINJWBTRXEBC-UHFFFAOYSA-N 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000007244 Zea mays Nutrition 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 239000013566 allergen Substances 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- 239000008168 almond oil Substances 0.000 description 1
- NGFMICBWJRZIBI-UHFFFAOYSA-N alpha-salicin Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=CC=C1CO NGFMICBWJRZIBI-UHFFFAOYSA-N 0.000 description 1
- BTBJBAZGXNKLQC-UHFFFAOYSA-N ammonium lauryl sulfate Chemical compound [NH4+].CCCCCCCCCCCCOS([O-])(=O)=O BTBJBAZGXNKLQC-UHFFFAOYSA-N 0.000 description 1
- 229940063953 ammonium lauryl sulfate Drugs 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 235000021302 avocado oil Nutrition 0.000 description 1
- 239000008163 avocado oil Substances 0.000 description 1
- LFYJSSARVMHQJB-GOSISDBHSA-N bakuchinol Natural products CC(C)=CCC[C@@](C)(C=C)C=CC1=CC=C(O)C=C1 LFYJSSARVMHQJB-GOSISDBHSA-N 0.000 description 1
- LFYJSSARVMHQJB-QIXNEVBVSA-N bakuchiol Chemical compound CC(C)=CCC[C@@](C)(C=C)\C=C\C1=CC=C(O)C=C1 LFYJSSARVMHQJB-QIXNEVBVSA-N 0.000 description 1
- 229940117895 bakuchiol Drugs 0.000 description 1
- KXXXNMZPAJTCQY-UHFFFAOYSA-N bakuchiol Natural products CC(C)CCCC(C)(C=C)C=Cc1ccc(O)cc1 KXXXNMZPAJTCQY-UHFFFAOYSA-N 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 229940073609 bismuth oxychloride Drugs 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 229940073669 ceteareth 20 Drugs 0.000 description 1
- 229940049297 cetyl acetate Drugs 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 239000011280 coal tar Substances 0.000 description 1
- 235000019868 cocoa butter Nutrition 0.000 description 1
- 229940110456 cocoa butter Drugs 0.000 description 1
- 239000003240 coconut oil Substances 0.000 description 1
- 235000019864 coconut oil Nutrition 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 1
- SASYSVUEVMOWPL-NXVVXOECSA-N decyl oleate Chemical class CCCCCCCCCCOC(=O)CCCCCCC\C=C/CCCCCCCC SASYSVUEVMOWPL-NXVVXOECSA-N 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 230000001627 detrimental effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 229940008099 dimethicone Drugs 0.000 description 1
- 239000004205 dimethyl polysiloxane Substances 0.000 description 1
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 1
- DKJLEUVQMKPSHB-UHFFFAOYSA-N dimethyl-[3-(octadecanoylamino)propyl]-(2-oxo-2-tetradecoxyethyl)azanium;chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCC(=O)NCCC[N+](C)(C)CC(=O)OCCCCCCCCCCCCCC DKJLEUVQMKPSHB-UHFFFAOYSA-N 0.000 description 1
- PCDVINMRZHPVSF-XXAVUKJNSA-L disodium;4-[2-[2-[[(z)-octadec-9-enoyl]amino]ethoxy]ethoxy]-4-oxo-3-sulfonatobutanoate Chemical class [Na+].[Na+].CCCCCCCC\C=C/CCCCCCCC(=O)NCCOCCOC(=O)C(S([O-])(=O)=O)CC([O-])=O PCDVINMRZHPVSF-XXAVUKJNSA-L 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 235000019441 ethanol Nutrition 0.000 description 1
- GJQLBGWSDGMZKM-UHFFFAOYSA-N ethylhexyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(CC)CCCCC GJQLBGWSDGMZKM-UHFFFAOYSA-N 0.000 description 1
- 210000000887 face Anatomy 0.000 description 1
- 229940007703 farnesyl acetate Drugs 0.000 description 1
- 210000001061 forehead Anatomy 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- FOYKKGHVWRFIBD-UHFFFAOYSA-N gamma-tocopherol acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1 FOYKKGHVWRFIBD-UHFFFAOYSA-N 0.000 description 1
- 125000005456 glyceride group Chemical group 0.000 description 1
- 229940049294 glyceryl stearate se Drugs 0.000 description 1
- 239000008169 grapeseed oil Substances 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 239000008172 hydrogenated vegetable oil Substances 0.000 description 1
- 230000000774 hypoallergenic effect Effects 0.000 description 1
- 230000004968 inflammatory condition Effects 0.000 description 1
- 229940078545 isocetyl stearate Drugs 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 229940093629 isopropyl isostearate Drugs 0.000 description 1
- 229940074928 isopropyl myristate Drugs 0.000 description 1
- XUGNVMKQXJXZCD-UHFFFAOYSA-N isopropyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(C)C XUGNVMKQXJXZCD-UHFFFAOYSA-N 0.000 description 1
- 229940075495 isopropyl palmitate Drugs 0.000 description 1
- 229940060384 isostearyl isostearate Drugs 0.000 description 1
- 229960005280 isotretinoin Drugs 0.000 description 1
- 230000003780 keratinization Effects 0.000 description 1
- 210000002510 keratinocyte Anatomy 0.000 description 1
- 229940100556 laureth-23 Drugs 0.000 description 1
- 229940033355 lauric acid Drugs 0.000 description 1
- 229940078812 myristyl myristate Drugs 0.000 description 1
- 229940078555 myristyl propionate Drugs 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- WNIFXKPDILJURQ-JKPOUOEOSA-N octadecyl (2s,4as,6ar,6as,6br,8ar,10s,12as,14br)-10-hydroxy-2,4a,6a,6b,9,9,12a-heptamethyl-13-oxo-3,4,5,6,6a,7,8,8a,10,11,12,14b-dodecahydro-1h-picene-2-carboxylate Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C)CC[C@@](C(=O)OCCCCCCCCCCCCCCCCCC)(C)C[C@H]5C4=CC(=O)[C@@H]3[C@]21C WNIFXKPDILJURQ-JKPOUOEOSA-N 0.000 description 1
- IIGMITQLXAGZTL-UHFFFAOYSA-N octyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCCCCCCC IIGMITQLXAGZTL-UHFFFAOYSA-N 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 229940075643 oleth-3 Drugs 0.000 description 1
- 229940055577 oleyl alcohol Drugs 0.000 description 1
- XMLQWXUVTXCDDL-UHFFFAOYSA-N oleyl alcohol Natural products CCCCCCC=CCCCCCCCCCCO XMLQWXUVTXCDDL-UHFFFAOYSA-N 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- BWOROQSFKKODDR-UHFFFAOYSA-N oxobismuth;hydrochloride Chemical compound Cl.[Bi]=O BWOROQSFKKODDR-UHFFFAOYSA-N 0.000 description 1
- 229940101267 panthenol Drugs 0.000 description 1
- 235000020957 pantothenol Nutrition 0.000 description 1
- 239000011619 pantothenol Substances 0.000 description 1
- 229940094335 peg-200 dilaurate Drugs 0.000 description 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
- 229940048845 polyglyceryl-3 diisostearate Drugs 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- NEOZOXKVMDBOSG-UHFFFAOYSA-N propan-2-yl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OC(C)C NEOZOXKVMDBOSG-UHFFFAOYSA-N 0.000 description 1
- 229940055019 propionibacterium acne Drugs 0.000 description 1
- 229940093625 propylene glycol monostearate Drugs 0.000 description 1
- 239000001944 prunus armeniaca kernel oil Substances 0.000 description 1
- 208000029561 pustule Diseases 0.000 description 1
- 150000004492 retinoid derivatives Chemical class 0.000 description 1
- 238000000518 rheometry Methods 0.000 description 1
- 238000005096 rolling process Methods 0.000 description 1
- NGFMICBWJRZIBI-UJPOAAIJSA-N salicin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=CC=C1CO NGFMICBWJRZIBI-UJPOAAIJSA-N 0.000 description 1
- 229940120668 salicin Drugs 0.000 description 1
- 231100000241 scar Toxicity 0.000 description 1
- 230000037387 scars Effects 0.000 description 1
- 239000008159 sesame oil Substances 0.000 description 1
- 235000011803 sesame oil Nutrition 0.000 description 1
- 210000004927 skin cell Anatomy 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 230000036555 skin type Effects 0.000 description 1
- 229940057950 sodium laureth sulfate Drugs 0.000 description 1
- SXHLENDCVBIJFO-UHFFFAOYSA-M sodium;2-[2-(2-dodecoxyethoxy)ethoxy]ethyl sulfate Chemical compound [Na+].CCCCCCCCCCCCOCCOCCOCCOS([O-])(=O)=O SXHLENDCVBIJFO-UHFFFAOYSA-M 0.000 description 1
- 229950004959 sorbitan oleate Drugs 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- WNIFXKPDILJURQ-UHFFFAOYSA-N stearyl glycyrrhizinate Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C)CCC(C(=O)OCCCCCCCCCCCCCCCCCC)(C)CC5C4=CC(=O)C3C21C WNIFXKPDILJURQ-UHFFFAOYSA-N 0.000 description 1
- ABTZKZVAJTXGNN-UHFFFAOYSA-N stearyl heptanoate Chemical compound CCCCCCCCCCCCCCCCCCOC(=O)CCCCCC ABTZKZVAJTXGNN-UHFFFAOYSA-N 0.000 description 1
- 229940098758 stearyl heptanoate Drugs 0.000 description 1
- 238000013517 stratification Methods 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 230000000475 sunscreen effect Effects 0.000 description 1
- 239000000516 sunscreening agent Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 description 1
- BORJONZPSTVSFP-UHFFFAOYSA-N tetradecyl 2-hydroxypropanoate Chemical compound CCCCCCCCCCCCCCOC(=O)C(C)O BORJONZPSTVSFP-UHFFFAOYSA-N 0.000 description 1
- YRZGMTHQPGNLEK-UHFFFAOYSA-N tetradecyl propionate Chemical compound CCCCCCCCCCCCCCOC(=O)CC YRZGMTHQPGNLEK-UHFFFAOYSA-N 0.000 description 1
- DZKXJUASMGQEMA-UHFFFAOYSA-N tetradecyl tetradecanoate Chemical compound CCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCC DZKXJUASMGQEMA-UHFFFAOYSA-N 0.000 description 1
- 238000011269 treatment regimen Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000010497 wheat germ oil Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- OWVLYQRCCIEOPF-QHTZZOMLSA-L zinc;(2s)-5-oxopyrrolidine-2-carboxylate Chemical compound [Zn+2].[O-]C(=O)[C@@H]1CCC(=O)N1.[O-]C(=O)[C@@H]1CCC(=O)N1 OWVLYQRCCIEOPF-QHTZZOMLSA-L 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/737—Galactomannans, e.g. guar; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/31—Hydrocarbons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/342—Alcohols having more than seven atoms in an unbroken chain
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/347—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/41—Amines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/41—Amines
- A61K8/416—Quaternary ammonium compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/42—Amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/46—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
- A61K8/463—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur containing sulfuric acid derivatives, e.g. sodium lauryl sulfate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
- A61K8/8141—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
- A61K8/8141—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
- A61K8/8152—Homopolymers or copolymers of esters, e.g. (meth)acrylic acid esters; Compositions of derivatives of such polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
- A61K8/817—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a single or double bond to nitrogen or by a heterocyclic ring containing nitrogen; Compositions or derivatives of such polymers, e.g. vinylimidazol, vinylcaprolactame, allylamines (Polyquaternium 6)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
- A61Q5/02—Preparations for cleaning the hair
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
- A61Q5/06—Preparations for styling the hair, e.g. by temporary shaping or colouring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
- A61Q5/12—Preparations containing hair conditioners
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
- A61K2800/30—Characterized by the absence of a particular group of ingredients
Definitions
- those same hair products can migrate to the skin through various mechanisms.
- the shampoo and conditioner unavoidably come into contact with the scalp, face, neck, chest, shoulders, and back, either through direct contact or as they are rinsed off and run down the skin in the shower.
- Many hair care products including rinse off products, such as shampoos and conditioners, are also designed to leave a residue even after the product is subsequently rinsed out of the hair.
- Leave in haircare products by design are not rinsed out and always leave a residue.
- This residue may be good for the hair, but can often cause problems for the skin.
- This residue can be deposited on the skin directly by direct contact with the skin on the scalp, and, for example, by dripping down from the hair to the face after application as well as when it runs down the person's face, neck, chest, shoulders, and/or back in the shower.
- This residue can also be deposited on a person's skin indirectly, when an object successively comes into contact with the person's hair, and then their skin. For example, if the person dries their hair with a towel, the residue can be transferred to other parts of their body via the towel; residue may also be transferred from a person's hair to their face from a pillowcase.
- hair care products are developed without consideration of the impact that the product will have on the user's skin, despite the fact that contact with the skin with each use is unavoidable.
- Many hair care products can also build up on the skin or scalp over time, particularly if the hair care product is intended to be left in for days at a time; as a result, the hair care products may have a dramatically detrimental effect on the skin of a user.
- Many hair care products also contain ingredients that can trigger irritation of the skin in some users.
- hair and skin treatments may also have incompatible regimens; for example, a person with parched hair strands resulting from coloration of their hair, may require hair products with significant amounts of oils and conditioning agents, some of which can be comedogenic to the skin.
- a “comedo” is an “acne lesion”, a hard blockage created from an excess of sebum combined with keratin (skin debris) in a pore which can lead to whiteheads, blackheads and pimples. Accordingly, the term, “comedogenic”, refers to ingredients or products that have a tendency to block pores and promote comedones or acne.
- Those with curly and/or frizzy hair may use smoothing products that traditionally contain ingredients such as oils and conditioning agents that can be comedogenic, or can become comedogenic in combination with other ingredients.
- ingredients such as oils and conditioning agents that can be comedogenic, or can become comedogenic in combination with other ingredients.
- some common hair smoothing products such as some silicone hair smoothing products, have not been found to be significantly comedogenic on their own, but have been found to increase the penetration of other ingredients in a formulation, which may result in a more comedogenic product. This means that hair care products can, in many cases, contribute to and exacerbate skin conditions such as acne (or “acne vulgaris”), the most common skin disease in the United States.
- Acne vulgaris affects up to 50 million people in the United States alone. Acne is not just a condition that affects teenagers. Acne is highly prevalent in adult women, with one study showing that 45% of women aged 21-30, 26% aged 31-40, and 12% aged 41-50 had clinical acne. Adult acne in women is also on the rise. According to the American Academy of Dermatology (AAD), acne can contribute to depression, anxiety, and poor self-image. It can also leave permanent scars.
- AAD American Academy of Dermatology
- Acne may arise when hair follicles (pilosebaceous units) become clogged.
- Acne is characterized by comedones, clogged pores in the skin, which can either be open comedones (“blackheads”) or closed comedones (“whiteheads”).
- Acne is also characterized by pimples, which can appear as inflammatory papules or pustules, cysts, or nodules.
- Acne is caused by several major mechanisms: inflammation, oil/sebum, follicular hyperkeratinization, propionibacterum acnes ( p. acnes ), a bacteria, and hormones.
- Sebum an oily substance secreted by the sebaceous glands of the skin, can cause dead skin cells to stick together, which can clog pores and plug hair follicles, causing acne.
- Sebum secretion has been correlated with acne severity, with high sebum secretion levels tended to be correlated with more severe acne; in some cases, a high sebum secretion rate may even be the decisive factor in inflammatory acne.
- P. acnes is a bacteria that lives on the skin and can also get inside the follicle and contribute to inflammation, causing inflammatory acne lesions, including papules, cysts, and nodules.
- Conventional belief was that all inflammatory acne lesions arose from comedones.
- acne has been identified to be a primary inflammatory condition. There is evidence that inflammation plays a role at all stages of acne development, and can even be observed subclincally before the formation of comedones.
- Acne can also be caused or exacerbated by certain cosmetics or styling products.
- “Acne cosmetica” is a form of acne that is caused by or exacerbated by the use of certain cosmetic products, including, though not limited to, makeup and sunscreen.
- “Acne cosmetica” typically results from a chemically-induced plugging of the hair follicles by these products.
- Certain cosmetic products can also produce folliculitis, or inflammation of the hair follicle, which appears as small bumps on the skin that can be skin-colored, pink, or red, having an appearance similar to acne.
- “pomade acne” is a similar condition to “acne cosmetica,” also resulting from chemically-induced plugging of the hair follicles, and characterized by bumps on the forehead caused by oily hair care styling products. This condition was originally described primarily in African American men. Both “acne cosmetica” and “pomade acne” may also be referred to generally as “acneiform eruptions.” Pomade acne has more recently been described as being an issue in all skin types, in both men and women due to hair products that smooth the hair, add shine, and reduce frizz. These products can contain oils, and waxes that clog pores, trap bacteria, and cause inflammation.
- the ingredients in these hair products that clog pores and cause acne are not limited to oils and waxes used for styling and conditioning, as other ingredients can be problematic.
- Comedogenic or potentially comedogenic components include PVP/DMAPA acrylates, cyclopentasiloxane, panthenol, dimethicone, some silicones (typically to a mild degree), Quaternium-70, oils, and petrolatum.
- These ingredients may be comedogenic themselves, or, as mentioned previously, may enhance the comedogenicity, irritation, and/or allergic potential of other ingredients.
- petrolatum itself is non-comedogenic, but is occlusive and can trap moisture and other ingredients in the hair follicles, causing stronger reactions to these ingredients.
- the AAD recommends using personal care products, including hair care products, which have one of the following labels: “non-comedogenic,” “non-acnegenic,” “oil-free,” or “won't clog pores.”
- these labels are not typically found on hair care products because hair care products are not typically formulated to be “non-comedogenic,” “non-acnegenic,” or “oil-free.”
- oils that are or have the potential to be comedogenic.
- other products such as silicones
- Many leave-in products also contain significant quantities of these oils and silicones that can be comedogenic, including, though not limited to, styling creams, gels, pomades, hairsprays, smoothing serums, heat styling sprays, anti-frizz serums, heat-protectants, and shine sprays.
- Other materials in hair care products are also potentially comedogenic.
- comedogenic or potentially comedogenic materials includes, but is not limited to, acetylated lanolin, acetylated lanolin alcohol, algin, almond oil, apricot kernel oil, avocado oil, grapeseed oil, bismuth oxychloride. butyl stearate, carrageenan, ceteareth 20. cetyl acetate. cocoa butter, coconut oil, coal tar, hydrogenated oils, D & C Red #17, D & C Red #21, D & C Red #3, D & C Red #30.
- Occlusive agents can often contribute to comedogenicity and acne. See Fulton, J. Soc. Cosmet. Chem., 40, 321-333 (November/December 1989) “Comedogenicity and irritancy of commonly used ingredients in skin care products” for a discussion of comedogenic materials.
- shampoos contain potentially irritating surfactants, such as sulfate-based surfactants; for example, sodium lauryl sulfate and ammonium lauryl sulfate are common surfactants that can cause irritation.
- Irritation to the skin can produce folliculitis and small papules on the skin, which may appear similar to acne. The folliculitis that occurs is indistinguishable from acne to the majority of hair care product users. Irritation of the follicle can also increase penetration of other materials in the hair care product into the skin follicles, increasing the potential comedogenicity and acnegenicity of many materials that could come into contact with the skin, including other materials in the hair care product formulation.
- Non-comedogenic and/or non-acnegenic hair care formulations may be disclosed.
- the hair care formulation may be any kind of hair care product, including, for example, a shampoo, conditioner, or a styling product such as a styling spray, a hair spray, a shine enhancer, a root spray, a hair masque, a gel, or a styling cream, or some combination thereof.
- a styling product such as a styling spray, a hair spray, a shine enhancer, a root spray, a hair masque, a gel, or a styling cream, or some combination thereof.
- Such a formulation may allow for the cleaning, conditioning, and/or styling of the hair of a user without causing or promoting irritation or acne on the skin of the user.
- Such a formulation may also help resolve skin irritation, breakouts, and/or acne.
- the formulation may be used as part of a two-step method for washing hair.
- a non-comedogenic and/or non-acnegenic shampoo is applied to cleanse the hair
- a non-comedogenic and/or non-acnegenic hair conditioner may be applied.
- certain hair care formulations that are non-comedogenic, or which are non-comedogenic and which do not tend to cause acne (non-acnegenic), may be disclosed.
- such hair care formulations may prevent, improve, and/or alleviate acne, acneiform eruptions, folliculitis, pimples, blemishes, and/or skin breakouts.
- hair care formulations may be used in isolation or as part of a regimen, as may be desired.
- hair care formulations may be used in a multi-step shower method. This method may include, in step 1, applying shampoo; and, in step 2, applying conditioner.
- hair care products may be used as part of a method for using a hair care formulation, or may be used independently, as desired. These products, or other products (such as shampoo, conditioner, and styling product) may be sold as part of a kit and designed to be compatible with or to complement one another, as may be desired.
- an exemplary embodiment of a non-comedogenic or non-acnegenic hair care product may include a keratinolytic agent, an anti-inflammatory agent, a sebum modulator, and/or antimicrobial agents, as well as other ingredients or additives, as desired.
- an anti-inflammatory agent may be added, but a keratinolytic agent, sebum modulator, or antimicrobial agent may not be added.
- a keratinolytic agent, sebum modulator, or antimicrobial agent may not be added.
- Other combinations may also be envisioned, as desired.
- a keratinolytic agent may be added to the composition, and may, for example, be used to modulate and correct abnormal follicular keratinization. This may help to prevent obstruction of the hair follicle and subsequent bacterial overgrowth.
- exemplary keratinolytic agents that may be used in the formulation include willowbark (salicin) or bakuchiol. In other exemplary embodiments, as discussed above, a keratinolytic agent may not be present.
- an anti-inflammatory agent may be added to the composition and may, for example, be used to reduce skin inflammation, therefore preventing and/or improving acne lesions, including comedones, papules, cysts, and nodules.
- exemplary anti-inflammatory agents that may be used in the formulation include bisabolol (an anti-inflammatory chamomile derivative), stearyl glycyrrhetinate, or grapefruit seed extract ( Citrus Grandis seed extract).
- Exemplary anti-irritant agents that may be used in the formulation include pea protein.
- a sebum modulator may be added to the composition and may, for example, be used to control the amount of sebum secreted by the sebaceous glands of the skin.
- measures to decrease sebum have been shown to improve acne.
- An exemplary embodiment of a formulation may make use of one or more topical sebum modulators, as desired.
- Systemic retinoids including isotretinoin, reduce sebum, and are one of the most powerful acne treatments available, but generally must be administered orally; as such, an exemplary embodiment of a formulation may be formulated to be compatible with a simultaneous systemic retinoid treatment or other oral or topical acne treatment of a patient, if desired.
- Exemplary sebum modulators that may be used in the formulation include Farnesyl Acetate, Panthenyl Triacetate, Tocopheryl Acetate, or grapefruit seed extract ( Citrus Grandis seed extract). In other exemplary embodiments, as discussed above, a sebum modulator may not be present.
- An exemplary embodiment of a formulation may also be formulated to be compatible with a separate topical acne treatment regimen, if desired.
- exemplary additives may be added for the purpose of protecting against pollution or protecting against ultraviolet light (UV), or for other purposes, as may be desired.
- exemplary multifunction additives that may be added to the formulation include algae extract, juice pressed from blackcurrant and raspberry leaves, butyl avocadate, zinc PCA, epilobium fleischeri extract, Laminaria Cloustoni extract, grapefruit seed extract ( Citrus Grandis seed extract), or Moringa oleifera seed extract (horse-radish tree).
- no multifunction additives may be added to the formulation, as may be desired.
- one or more high molecular weight ingredients may be added to the formulation.
- a large constituent such as a polymer of polyethylene glycol (PEG) may be added to the formulation. This may serve to reduce the comedogenicity of the overall formulation.
- PEG polyethylene glycol
- one or more of a polar sugar or a heavy metal may be added to the formulation to reduce the comedogenicity of the overall formulation.
- a polar sugar or a heavy metal may be added to the formulation.
- zinc may be added to the formulation.
- the degree of etholxylation of one or more of the molecules used in the formulation may be increased, or one or more ethoxylated materials may be added.
- ingredients which are known to be comedogenic or which are potentially comedogenic may be excluded from the formulation.
- the formulation may be oil-free, and free of laureth-4, isopropyl myristate and its analogs, lanolins, waxes, and certain conditioning agents, as well as other comedogenic or acnegenic compounds or compositions listed above or in a previous section. Occlusive agents, such as some of the above materials, can often contribute to comedogenicity and acne.
- ingredients which are known to be irritating or potentially irritating, or ingredients that function as common allergens or which are not known to be hypoallergenic may also be excluded from the formulation.
- the formulation may be sulfate-free.
- ingredients that can exacerbate the comedogenic or acnegenic properties of another ingredient but which do not themselves have significant comedogenic or acnegenic properties such as silicone, may also be excluded.
- a silicone substitute such as hemisqualane (a non comedogenic silicone substitute that has skin benefits) may be substituted for silicone in some quantity.
- silicone or another ingredient that can exacerbate the comedogenic or acnegenic effects of another ingredient may be included, and the comedogenic and acnegenic properties of the formulation may be controlled by controlling other ingredients of the formulation instead.
- ingredients which are known to be comedogenic or which are known to potentially be comedogenic when present in a formulation at a particular level may be kept below the level at which they are comedogenic.
- a non-comedogenic conditioner may be provided by reducing but not eliminating the quantity of cetearyl alcohol present in a formulation; cetearyl alcohol may be comedogenic in high concentrations and minimally reactive at low concentrations.
- the products will also be paraben-free, formaldehyde-free, and phthalate-free, or may not have any of those components in any significant quantities.
- the pH of the formulation may be controlled at a desirable level, which may serve to reduce irritation and inflammation. It may be understood that the skin of a typical person is slightly acidic, typically having a pH of around 5.5 to 6.5, whereas many soaps, particularly bar soaps, may be formulated to have a pH that is slightly basic (around 8 to 9). This may cause skin irritation and inflammation. According to an exemplary embodiment, one or more acids may be added to the formulation such that the formulation has a pH that is neutral or slightly acidic, as desired.
- different optimal ranges may be targeted for different non-comedogenic and/or non-acnegenic hair care formulations; for example, in an exemplary embodiment, the optimal pH of the shampoo may be 5.5-6.5 and the optimal pH of the conditioner may be 4.8-5.3. In other exemplary embodiments, pH may be controlled at another level, if desired; in other exemplary embodiments, no additives may be added to the composition in order to control pH.
- the composition may also be formulated to have desirable qualities as a hair care product.
- the composition may be rinseable and designed to leave only skin-friendly residue when rinsed. This may further minimize the potential for irritation or comedogenicity from the product.
- the rinseability of the product may also provide other benefits, such as other benefits to the skin, such as may be desired.
- the composition may be formulated to be color-safe or may otherwise be formulated to have minimal impact on color-treated hair.
- variations of the composition may be formulated for use in specialized hair care products.
- stratification between said hair care products may be based on hair type, benefit, or intended customer.
- variations of an exemplary composition may be prepared specifically for and marketed at women, men, teens, and others.
- variations of an exemplary composition may be prepared specifically for curly hair, damaged hair, dry hair, fine or flat hair, as well as more typical or normal hair.
- variations of an exemplary composition may be prepared specifically for anti-frizzing, for promoting shine, for smoothing hair, for strengthening hair, or for any other purposes as may be desired.
- An exemplary formulation of a hair care product formulated to have non-comedogenic and/or non-acnegenic properties may be disclosed in table 1 and may be made by combining the following components in the proportions stated below.
- the hair care product in table 1 may be used as a shampoo.
- Non-Comedogenic/Acnegenic Shampoo Exemplary Compositions
- Ingredient Broad % Preferred % Part A Water 10.0-70.0 20.0-40.0 Disodium EDTA 0.00-1.00 0.01-0.20 Part B Glycerin 0.00-10.0 0.01-3.00 Guar Hydroxypropyltrimonium 0.05-5.00 0.01-0.50 chloride Part C
- Citric acid 0.00-2.00 0.01-1.00 Part D Phenoxyethanol 0.01-1.00 0.01-1.00 Ethylhexylglycerin 0.01-1.00 0.01-0.50
- Cocamidopropylamine oxide 1.00-20.0 5.00-10.0
- Water 0.00-8.00 2.00-8.00 Acrylates copolymer 1.00-15.0 2.00-6.00 Part F C13-C15 alkane 0.01-10.0 0.01-1.50
- an exemplary formulation of hair care product may include phenoxyethanol and ethylhexylglycerin as separate components rather than including Euxyl PE 9010. This may allow the component chemicals (such as, again, phenoxyethanol and ethylhexylglycerin) to be provided in different proportions than are found in the chemical composition provided under the trade name.
- acrylates copolymer listed in table 1 may be that sold under the trade name, Carbopol Aqua SF-1; however, it will be understood by those skilled in the art that any suitable lightly cross-linked rheology modifying acrylate copolymer may be employed in the practice of the invention.
- an exemplary hair care product formulation of table 1 may be prepared according to the following process or a process similar to the following.
- a sanitized mixing vessel may be prepared, and a quantity of deionized water may be added to the sanitized mixing vessel.
- the remaining components of Part A which in the exemplary case shown in table 2 may be Disodium EDTA, may then be mixed into the mixing vessel.
- the ingredients of part B may be premixed and may then be added to the batch.
- the ingredients may be mixed into the batch until the batch is uniform.
- the ingredients of part C may then be added to the combined batch, and again mixed until the resulting batch is completely smooth.
- the combined parts A, B, and C may then be heated.
- the combined batch may be heated to a temperature within a range of 60 to 65° C.
- Part D The ingredients of Part D may then be added.
- the resulting batch may be mixed until all solids are melted and the batch is uniform. Once the batch has been fully mixed, the batch may be cooled to a temperature within a range of 40 to 45° C.
- the parts of part E may be added.
- the components of part E may be pre-mixed prior to addition, which may be done, for example, concurrently with another step preceding the addition of components in part E.
- the resulting batch may be mixed until uniform.
- the ingredients of part F may be added, and likewise mixed until uniform.
- the batch may then be cooled to a temperature of approximately 35° C.
- the pH of the batch may at this time be adjusted to a pH within a range of 6.50 to 6.75.
- the resulting composition may be a hair care product having the appearance of semi-viscous pearlized gel.
- the color may be pearlescent white to off-white, which may in some exemplary embodiments be adjusted if desired.
- the odor may be characteristic of the fragrance added to the composition; in some exemplary embodiments, the fragrance may be reduced or left out of the composition in order to produce an odorless composition.
- the composition may have a pH at 25° C. of between 6.5 and 7.0, a viscosity at 25° C. (RVT), at spindle 5 at 20 rpm, of between 1000 and 12,000 cPs, and a specific gravity at 25° C. of between 0.98 and 1.03.
- the composition may be kept to a low level of viable bacterial or fungal cells or other colony-forming units (CFU), of approximately ⁇ 10 CFU/g; the composition may also be kept free of pathogens.
- CFU colony-forming units
- one or more small-scale batches such as lab or pilot batches, may be made prior to large-scale manufacturing. Adjustments may be made to the production process based on, for example, the results of a batch made in a particular production environment.
- FIG. 2 Another exemplary formulation of a hair care product formulated to have non-comedogenic and/or non-acnegenic properties may be disclosed in table 2 and may be made by combining the following components in the proportions stated below.
- the hair care product in table 2 may be used as a hair conditioner.
- Non-Comedogenic/Acnegenic Hair Conditioner Exemplary Compositions Ingredient Broad % Preferred % Part A Water 50.0-90.0 60.0-90.0 Disodium EDTA 0.00-1.00 0.01-0.10 Phenoxyethanol 0.10-5.00 0.75-1.25 Ethylhexylglycerin 0.10-2.00 0.10-0.50 Citric acid 0.01-1.00 0.01-0.50 Stearamidopropyl dimethylamine 1.00-10.0 1.00-2.50 Polysorbate 80 0.00-5.00 0.10-1.00 Part B Cetearyl alcohol 0.50-10.0 1.00-5.00 Behentrimonium chloride 0.10-5.00 0.50-3.00 Cetyl palmitate 0.50-5.00 1.00-4.00 C13-C15 alkane 0.50-15.0 2.00-7.00 Shea butter cetyl esters 0.10-8.00 0.50-2.00 Part C Glycerin 0.00-10.0 0.10-2.00 Bisabolol 0.01-1.00 0.01-0.50 Fragrance 0.00-5.00 0.50-2.00
- an exemplary hair care product formulation of table 2 may be prepared according to the following process or a process similar to the following.
- a sanitized mixing vessel may be prepared, and a quantity of deionized water may be added to the sanitized mixing vessel. This DI water may then be heated to a temperature within the ranges of 80 to 85° C.
- the remaining components of Part A may then be mixed into the mixing vessel.
- the remaining components of Part A may be added in an order or sequence, which may for example be the order in which they are shown in the table.
- the ingredients may be added only once the previous ingredient has been fully dissolved.
- the phenoxyethanol of part A may be added, mixed until fully dissolved, and only then will the ethylhexylglycerin of part B be added.
- the components of part B may be combined in a separate mixing vessel.
- the components of part B may be heated to a temperature in the range of 80 to 85° C. after combination, and may then be mixed until uniform.
- the components of part B may then be combined with the components of part A, for example by adding the components of part B to the mixing vessel of part A.
- the resulting batch may then be mixed until it is smooth and uniform.
- the batch may then be cooled to a temperature within the range of 35 to 40° C.; according to an exemplary embodiment, mixing may be continued during this cooling process.
- the ingredients of part C may then be added to the combined batch of parts A and B.
- ingredients may be added alone or in combination, as may be desired.
- the resulting batch may be mixed until uniform; following this, it may continue to be mixed and may be cooled (for example by ambient temperature) until the temperature of the batch reaches a temperature between 30 and 35° C.
- the resulting composition may be a hair care product having the appearance of viscous cream.
- the color may be white to off-white, which may in some exemplary embodiments be adjusted if desired.
- the odor may be characteristic of the fragrance added to the composition; in some exemplary embodiments, the fragrance may be reduced or left out of the composition in order to produce an odorless composition.
- the composition may have a pH at 25° C. of between 3.8 and 5.5 a viscosity at 25° C. (RVT), at spindle 5 at 20 rpm, of between 2000 and 30,000 cPs, and a specific gravity at 25° C. of between 0.98 and 1.03.
- the composition may be kept to a low level of viable bacterial or fungal cells or other colony-forming units (CFU), of approximately ⁇ 10 CFU/g; the composition may also be kept free of pathogens.
- CFU colony-forming units
- FIG. 3 Another exemplary formulation of a hair care product formulated to have non-comedogenic and/or non-acnegenic properties may be disclosed in table 3 and may be made by combining the following components in the proportions stated below.
- the hair care product in table 3 may be used as a curly styling cream.
- an exemplary hair care product formulation of table 3 may be prepared according to the following process or a process similar to the following.
- a sanitized mixing vessel add disodium EDTA and water from Part A. Begin heating to 75-80° C. while mixing. Add remaining ingredients of Part A. Mix with heat until clear and all solids are dissolved.
- a separate vessel combine ingredients in Part B. Heat Part B to 75-80° C. and mix until uniform. Add Part B to Part A and mix until smooth and uniform. Add Part C to batch, mix until uniform and cool to 35-40° C. Add ingredients in Part D and mix until uniform. Continue mixing batch until temperate reaches 30-35° C.
- the product has the appearance of a white viscous cream with a pH@ 25° C.: 3.8-4.2; viscosity @ 25° C. (RVT): Spindle 5, 20 RPM 4,000-8,000 cPs; specific gravity @ 25° C.: 0.98-1.03; microbiology ⁇ 10 CFU/g, No pathogens
- FIG. 4 Another exemplary formulation of a hair care product formulated to have non-comedogenic and/or non-acnegenic properties may be disclosed in table 4 and may be made by combining the following components in the proportions stated below.
- the hair care product in table 4 may be used as a blow dry styling cream.
- an exemplary hair care product formulation of table 4 may be prepared according to the following process or a process similar to the following.
- a sanitized mixing vessel add disodium EDTA and water from Part A. Begin heating to 75-80° C. while mixing. Add remaining ingredients of Part A. Mix with heat until clear and all solids are dissolved.
- a separate vessel combine ingredients in Part B. Heat Part B to 75-80° C. and mix until uniform. Add Part B to Part A and mix until smooth and uniform. Continue mixing and cool to 35-40° C. Add ingredients in Part C and mix until uniform. Continue mixing batch until temperate reaches 30-35° C.
- the product has the appearance of a white viscous cream with a pH@ 25° C.: 3.8-4.2; viscosity @ 25° C. (RVT): Spindle 5, 20 RPM 3,000-8,000 cPs; specific gravity @ 25° C.: 0.98-1.03; microbiology ⁇ 10 CFU/g, No pathogens
- one or more small-scale batches such as lab or pilot batches, may be made prior to large-scale manufacturing. Adjustments may be made to the production process based on, for example, the results of a batch made in a particular production environment.
- compositions may also be envisioned, for example for other compositions of shampoos or conditioners or for other types of hair care products, such as styling gels or even combined shampoos and conditioners.
- some embodiments may have relative compositions different from those shown; an exemplary composition may have a higher weight percent of one component chemical and a lower weight percent of a second component chemical.
- Equivalent or substantially equivalent component chemicals may also be substituted for chemicals within a composition. Appropriate substitutions may be appreciated by one of skill in the art.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Dermatology (AREA)
- Cosmetics (AREA)
Abstract
Description
TABLE 1 |
Non-Comedogenic/Acnegenic Shampoo Exemplary Compositions |
Ingredient | Broad % | Preferred % | ||
Part A | Water | 10.0-70.0 | 20.0-40.0 |
Disodium EDTA | 0.00-1.00 | 0.01-0.20 | |
Part B | Glycerin | 0.00-10.0 | 0.01-3.00 |
Guar Hydroxypropyltrimonium | 0.05-5.00 | 0.01-0.50 | |
chloride | |||
Part C | Citric acid | 0.00-2.00 | 0.01-1.00 |
Part D | Phenoxyethanol | 0.01-1.00 | 0.01-1.00 |
Ethylhexylglycerin | 0.01-1.00 | 0.01-0.50 | |
Polyquaternium-7 | 0.50-10.0 | 0.50-5.00 | |
Sodium lauroyl methyl isethionate | 10.0-70.0 | 30.0-60.0 | |
Cocamidopropylamine oxide | 1.00-20.0 | 5.00-10.0 | |
Glycol distearate | 0.00-10.0 | 0.50-1.00 | |
Part E | Water | 0.00-8.00 | 2.00-8.00 |
Acrylates copolymer | 1.00-15.0 | 2.00-6.00 | |
Part F | C13-C15 alkane | 0.01-10.0 | 0.01-1.50 |
Bisabolol | 0.01-1.00 | 0.01-0.50 | |
Fragrance | 0.00-3.00 | 0.01-1.00 | |
Aminomethyl propanol | 0.01-5.00 | 0.01-1.00 | |
TABLE 2 |
Non-Comedogenic/Acnegenic Hair Conditioner |
Exemplary Compositions |
Ingredient | Broad % | Preferred % | ||
Part A | Water | 50.0-90.0 | 60.0-90.0 |
Disodium EDTA | 0.00-1.00 | 0.01-0.10 | |
Phenoxyethanol | 0.10-5.00 | 0.75-1.25 | |
Ethylhexylglycerin | 0.10-2.00 | 0.10-0.50 | |
Citric acid | 0.01-1.00 | 0.01-0.50 | |
Stearamidopropyl dimethylamine | 1.00-10.0 | 1.00-2.50 | |
Polysorbate 80 | 0.00-5.00 | 0.10-1.00 | |
Part B | Cetearyl alcohol | 0.50-10.0 | 1.00-5.00 |
Behentrimonium chloride | 0.10-5.00 | 0.50-3.00 | |
Cetyl palmitate | 0.50-5.00 | 1.00-4.00 | |
C13-C15 alkane | 0.50-15.0 | 2.00-7.00 | |
Shea butter cetyl esters | 0.10-8.00 | 0.50-2.00 | |
Part C | Glycerin | 0.00-10.0 | 0.10-2.00 |
Bisabolol | 0.01-1.00 | 0.01-0.50 | |
Fragrance | 0.00-5.00 | 0.50-2.00 | |
TABLE 3 |
Non-Comedogenic/Acnegenic Curly Styling |
Cream Exemplary Compositions |
Ingredient | Broad % | Preferred % | ||
Part A | Water | 50.0-90.0 | 75.0-85.0 |
Disodium EDTA | 0.00-1.00 | 0.05-0.20 | |
Phenoxyethanol | 0.10-5.00 | 0.75-1.25 | |
Ethylhexylglycerin | 0.10-2.00 | 0.10-0.50 | |
Citric acid | 0.01-1.00 | 0.01-0.50 | |
Stearamidopropyl dimethylamine | 1.00-10.0 | 1.00-2.50 | |
Polysorbate 80 | 0.00-5.00 | 0.10-1.00 | |
Part B | Cetearyl alcohol | 0.50-10.0 | 1.00-5.00 |
Behentrimonium chloride | 0.10-5.00 | 0.50-3.00 | |
Squalene | 0.00-8.00 | 0.50-5.00 | |
C13-C15 alkane | 0.50-15.0 | 1.00-5.00 | |
Shea butter cetyl esters | 0.10-8.00 | 0.50-5.00 | |
Part C | Polyimide-1 | 0.00-3.00 | 0.10-1.00 |
Part D | Puricare ™ LS9727* | 0.00-8.00 | 1.00-3.00 |
Bisabolol | 0.01-1.00 | 0.01-1.00 | |
Hydrolyzed Pea Protein | 0.00-8.00 | 0.50-2.00 | |
Keratrix ™** | 0.00-10.0 | 1.50-4.50 | |
Fragrance | 0.00-5.00 | 0.01-2.00 | |
*Includes water, glycerin, moringa Oleifera seed extract | |||
**Includes water, glycerin, hydrolyzed ceratonia siliqua seed extract, zea mays starch, guar hydroxypropyltrimonium chloride, polyquaternium-7 |
TABLE 4 |
Non-Comedogenic/Acnegenic Blow Dry Styling |
Cream Exemplary Compositions |
Ingredient | Broad % | Preferred % | ||
Part A | Water | 50.0-90.0 | 75.0-85.0 |
Disodium EDTA | 0.00-1.00 | 0.05-0.20 | |
Phenoxyethanol | 0.10-5.00 | 0.75-1.25 | |
Ethylhexylglycerin | 0.10-2.00 | 0.10-0.50 | |
Citric acid | 0.01-1.00 | 0.01-0.50 | |
Stearamidopropyl dimethylamine | 1.00-10.0 | 1.00-2.50 | |
Polysorbate 80 | 0.00-5.00 | 0.10-1.00 | |
Part B | Cetearyl alcohol | 1.00-5.00 | 1.00-5.00 |
Behentrimonium chloride | 0.50-3.00 | 0.50-3.00 | |
Squalene | 0.50-5.00 | 0.50-5.00 | |
C13-C15 alkane | 1.00-5.00 | 1.00-5.00 | |
Shea butter cetyl esters | 0.50-5.00 | 0.50-5.00 | |
Part C | Puricare ™ LS9727 | 0.00-8.00 | 1.00-3.00 |
Bisabolol | 0.01-1.00 | 0.01-1.00 | |
Hydrolyzed Pea Protein | 0.00-8.00 | 0.50-2.00 | |
Keratrix ™ | 0.00-10.0 | 1.50-4.50 | |
Fragrance | 0.00-5.00 | 0.01-2.00 | |
Claims (19)
Priority Applications (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/US2017/036745 WO2017214497A1 (en) | 2016-06-10 | 2017-06-09 | Non-comedogenic hair and scalp care formulations and method for use |
CA3026108A CA3026108A1 (en) | 2016-06-10 | 2017-06-09 | Non-comedogenic hair and scalp care formulations and method for use |
JP2019516919A JP6992057B2 (en) | 2016-06-10 | 2017-06-09 | Non-acne-forming hair and scalp care products and how to use them |
US15/618,420 US9949915B2 (en) | 2016-06-10 | 2017-06-09 | Non-comedogenic and non-acnegenic hair and scalp care formulations and method for use |
US15/957,238 US10159637B2 (en) | 2016-06-10 | 2018-04-19 | Non-comedogenic and non-acnegenic hair and scalp care formulations and method for use |
US16/192,676 US11160746B2 (en) | 2016-06-10 | 2018-11-15 | Non-comedogenic and non-acnegenic hair and scalp care formulations and method for use |
US16/739,774 US10813872B2 (en) | 2016-06-10 | 2020-01-10 | Hair and scalp formulations |
US17/496,680 US20220079865A1 (en) | 2016-06-10 | 2021-10-07 | Non-comedogenic and non-acnegenic hair and scalp care formulations and method for use |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201662348510P | 2016-06-10 | 2016-06-10 | |
US15/618,420 US9949915B2 (en) | 2016-06-10 | 2017-06-09 | Non-comedogenic and non-acnegenic hair and scalp care formulations and method for use |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US15/957,238 Continuation US10159637B2 (en) | 2016-06-10 | 2018-04-19 | Non-comedogenic and non-acnegenic hair and scalp care formulations and method for use |
Publications (2)
Publication Number | Publication Date |
---|---|
US20170354585A1 US20170354585A1 (en) | 2017-12-14 |
US9949915B2 true US9949915B2 (en) | 2018-04-24 |
Family
ID=60572142
Family Applications (5)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US15/618,420 Active US9949915B2 (en) | 2016-06-10 | 2017-06-09 | Non-comedogenic and non-acnegenic hair and scalp care formulations and method for use |
US15/957,238 Active US10159637B2 (en) | 2016-06-10 | 2018-04-19 | Non-comedogenic and non-acnegenic hair and scalp care formulations and method for use |
US16/192,676 Active US11160746B2 (en) | 2016-06-10 | 2018-11-15 | Non-comedogenic and non-acnegenic hair and scalp care formulations and method for use |
US16/739,774 Active US10813872B2 (en) | 2016-06-10 | 2020-01-10 | Hair and scalp formulations |
US17/496,680 Pending US20220079865A1 (en) | 2016-06-10 | 2021-10-07 | Non-comedogenic and non-acnegenic hair and scalp care formulations and method for use |
Family Applications After (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US15/957,238 Active US10159637B2 (en) | 2016-06-10 | 2018-04-19 | Non-comedogenic and non-acnegenic hair and scalp care formulations and method for use |
US16/192,676 Active US11160746B2 (en) | 2016-06-10 | 2018-11-15 | Non-comedogenic and non-acnegenic hair and scalp care formulations and method for use |
US16/739,774 Active US10813872B2 (en) | 2016-06-10 | 2020-01-10 | Hair and scalp formulations |
US17/496,680 Pending US20220079865A1 (en) | 2016-06-10 | 2021-10-07 | Non-comedogenic and non-acnegenic hair and scalp care formulations and method for use |
Country Status (5)
Country | Link |
---|---|
US (5) | US9949915B2 (en) |
EP (1) | EP3468530A4 (en) |
JP (1) | JP6992057B2 (en) |
CA (1) | CA3026108A1 (en) |
WO (1) | WO2017214497A1 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10813872B2 (en) * | 2016-06-10 | 2020-10-27 | Clarity Cosmetics Inc. | Hair and scalp formulations |
US11975087B2 (en) | 2020-03-30 | 2024-05-07 | Colgate-Palmolive Company | Sulfate-free personal care compositions and methods for preventing and treating pollution damage to skin |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL276129B2 (en) * | 2018-01-17 | 2024-04-01 | Sharon Laboratories Ltd | Antimicrobial preservative compounds |
FR3125416B1 (en) * | 2021-07-22 | 2024-11-22 | Oreal | Cosmetic composition comprising at least one fatty amine, at least 6% by weight of at least one solid fatty substance and at least one liquid fatty substance. |
EP4565334A1 (en) * | 2022-08-04 | 2025-06-11 | Clarity Cosmetics Inc. | Skin and hair care formulations |
Citations (48)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5863546A (en) | 1997-03-02 | 1999-01-26 | Swinehart; James M | Cosmetic composition |
US6312675B1 (en) | 2000-09-14 | 2001-11-06 | Jeffrey Alan Deane | Hair cleaner |
US6406708B1 (en) | 1998-05-12 | 2002-06-18 | Interhealth Ab | Therapeutic compositions |
US20020143063A1 (en) | 2001-01-29 | 2002-10-03 | Alvarado Robert M. | Hair conditioner composition that is non-irritating to the eyes |
US20030039619A1 (en) | 2000-01-28 | 2003-02-27 | Joachim Bunger | Galenic formulation |
US6723309B1 (en) | 2002-06-10 | 2004-04-20 | Jeffrey Alan Deane | Hair cleansing conditioner |
US20040186042A1 (en) | 2001-07-09 | 2004-09-23 | Gerhard Schmaus | Iso-$g(b)-bisabolol as fragrance and aroma substance |
US20040258651A1 (en) | 2003-06-18 | 2004-12-23 | Goldschmidt Ag | Use of alkylguanidine compounds for the treatment and after-treatment of hair |
US20040258652A1 (en) | 2003-06-18 | 2004-12-23 | Goldschmidt Ag | Hair treatment compositions and hair after-treatment compositions for protection against damage by chemical treatment and for the repair of already damaged hair comprising as active substances alkylguanidine compounds |
WO2005018629A1 (en) | 2003-08-12 | 2005-03-03 | Yarbrough William M | Treatment for acne vulgaris and method of use |
US6923954B2 (en) | 2001-08-06 | 2005-08-02 | Kao Corporation | Conditioner |
US20060057075A1 (en) | 2004-08-02 | 2006-03-16 | Moshe Arkin | Pharmaceutical and cosmeceutical wash-off mousse shampoo compositions, processes for preparing the same and uses thereof |
US7182939B2 (en) | 1998-10-26 | 2007-02-27 | Shiseido Company, Ltd. | Hair tonic composition |
US20070082017A1 (en) | 2004-01-10 | 2007-04-12 | Tseng Scheffer C | Lipid compositions and methods of use |
US20070166241A1 (en) | 2000-04-21 | 2007-07-19 | Baker Amy E | Salicylic acid acne spray formulations and methods for treating acne with same |
US20070286838A1 (en) * | 2006-06-09 | 2007-12-13 | T.F.H. Publications, Inc. | Tamanu Oil Products |
US20080275118A1 (en) | 2008-06-12 | 2008-11-06 | Shaw Mari M | Health and cosmetic composition and regime for stimulating hair growth and thickening on the head, including the scalp, eyelashes, and eyebrows, and which discourages hair loss |
US20090226381A1 (en) | 2008-02-11 | 2009-09-10 | Sarah Maillefer | Method and Composition for Reducing the Drying Time of Hair |
US7691792B1 (en) | 2009-09-21 | 2010-04-06 | Amyris Biotechnologies, Inc. | Lubricant compositions |
US20110256249A1 (en) * | 2010-04-16 | 2011-10-20 | Doreen Campbell | Hair and scalp care formulations for treating and preventing acne and related skin conditions |
US8092813B1 (en) | 2007-12-28 | 2012-01-10 | Novartis Ag | Polychlorinated biphenyls and squalene-containing adjuvants |
US20120082629A1 (en) | 2010-09-01 | 2012-04-05 | Basf Se | Associative Thickeners For Aqueous Preparations |
US20120093755A1 (en) * | 2010-10-15 | 2012-04-19 | Maneworx Inc. | Compositions and methods for treating keratin based fibers |
US8173143B2 (en) | 2005-06-02 | 2012-05-08 | Tecco Michelle A | Personal skin care compositions containing anti-flammatory and anti-microbial agents |
EP1693050B1 (en) | 2005-02-02 | 2012-07-11 | Unilever PLC | Care product for skin and/or hair, and the use thereof |
US20120189684A1 (en) | 2009-07-17 | 2012-07-26 | Reckitt Benckiser Healthcare International Limited | Skincare Compositions |
US20120289590A1 (en) | 2011-05-11 | 2012-11-15 | Gerry Ritterman | Hair cosmetic composition |
EP2214631B1 (en) | 2007-12-05 | 2013-04-03 | Henkel AG & Co. KGaA | Hair shampoo having a surfactant/thickening combination |
US20130090279A1 (en) * | 2011-10-07 | 2013-04-11 | The Procter & Gamble Company | Shampoo Composition Containing a Gel Network |
US8586814B2 (en) | 2010-05-21 | 2013-11-19 | Amyris, Inc. | Squalane and isosqualane compositions and methods for preparing the same |
US20140154200A1 (en) * | 2011-07-21 | 2014-06-05 | Rhodia Operations | Guar hydroxypropyltrimethylammonium chloride and uses thereof in hair treatment compositions |
US20140187518A1 (en) | 2012-12-28 | 2014-07-03 | Rak Holdings Llc | Anti-itch scalp treatment compositions and combinations |
US20140186284A1 (en) | 2012-12-27 | 2014-07-03 | L'oreal | Conditioning compositions for keratinous substrates |
WO2014134620A1 (en) | 2013-03-01 | 2014-09-04 | Envy Medical, Inc. | Acne solution |
US8957112B2 (en) | 2006-12-21 | 2015-02-17 | Galderma Research & Development | Cream gels comprising at least one retinoid and benzoyl peroxide |
US20150139929A1 (en) * | 2011-12-22 | 2015-05-21 | Nicholas John Dixon | Personal care composition and method of use thereof |
WO2015164433A1 (en) | 2014-04-21 | 2015-10-29 | Envy Medical, Inc. | Acne solution |
WO2015175333A1 (en) | 2014-05-16 | 2015-11-19 | Restorsea, Llc | Biphasic cosmetic |
US20160008297A1 (en) | 2012-08-23 | 2016-01-14 | B.R.A.I.N. Biotechnology Research And Information Network Ag | Compounds for preventing, reducing and/or alleviating itchy skin condition(s) |
WO2016012757A1 (en) | 2014-07-22 | 2016-01-28 | Perachem Limited | Hair conditioning compositions |
WO2016018315A1 (en) | 2014-07-30 | 2016-02-04 | Younique, Llc | Formulations, methods and devices for periorbital skin rejuvenation |
US9271956B2 (en) | 2012-08-20 | 2016-03-01 | Bionoox Suisse Sa | Companion cosmetic compositions |
WO2016040757A1 (en) | 2014-09-12 | 2016-03-17 | The Procter & Gamble Company | Cosmetic compositions and methods for inhibiting melanin synthesis |
US20160374352A1 (en) | 2014-03-10 | 2016-12-29 | The Trustees Of Columbia University In The City Of | Botanical antimicrobial compositions |
WO2017034384A1 (en) | 2015-08-24 | 2017-03-02 | Rīgas Stradiņa Universitāte | Epidermal lipid barrier restoring cream for facial skin, neck and decollete area for metabolic syndrome patients |
US20170096418A1 (en) * | 2015-10-01 | 2017-04-06 | Senomyx, Inc. | Compounds useful as modulators of trpm8 |
WO2017108902A1 (en) | 2015-12-23 | 2017-06-29 | Novartis Ag | Oil-in-water emulsions including retinoic acid |
WO2018000060A1 (en) | 2016-06-30 | 2018-01-04 | L'oreal | Anti-acne sunscreen composition |
Family Cites Families (315)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3335593A1 (en) * | 1983-09-30 | 1985-04-11 | Diamalt AG, 8000 München | GELLING AND THICKENING AGENT BASED ON CASSIA GALACTOMANNANS |
US5306489A (en) * | 1992-07-24 | 1994-04-26 | Revlon Consumer Products Corporation | Hair care products containing N-alkoxyalkylamides |
US6238682B1 (en) | 1993-12-13 | 2001-05-29 | The Procter & Gamble Company | Anhydrous skin lotions having antimicrobial components for application to tissue paper products which mitigate the potential for skin irritation |
US5759527A (en) * | 1996-10-02 | 1998-06-02 | Colgate-Palmolive Company | Hair conditioning composition |
US6193986B1 (en) | 1997-02-25 | 2001-02-27 | The Nisshin Oil Mills, Ltd. | Oily composition with increased stability and process for producing the same |
JPH1112177A (en) | 1997-06-25 | 1999-01-19 | Teikoku Seiyaku Co Ltd | Stable aspirin-containing preparation for external use |
DE59802564D1 (en) | 1997-08-18 | 2002-01-31 | Neubourg Stephanie | FOAM-SKIN CREAM |
JP3211740B2 (en) | 1997-08-28 | 2001-09-25 | ダイキン工業株式会社 | Cosmetics |
US6165493A (en) | 1997-10-22 | 2000-12-26 | New York Blood Center, Inc. | "Methods and compositions for decreasing the frequency of HIV, herpesvirus and sexually transmitted bacterial infections" |
JPH11139928A (en) | 1997-10-31 | 1999-05-25 | Shiseido Co Ltd | Emulsion-type pack cosmetic |
BR9814693B1 (en) | 1997-11-19 | 2011-04-19 | fluidized polymer suspensions of cationic polysaccharides in softeners and process for preparing a personal care composition. | |
US7393630B2 (en) | 1997-12-16 | 2008-07-01 | Novartis Vaccines And Diagnostics, Inc. | Use of microparticles combined with submicron oil-in-water emulsions |
JP4282787B2 (en) | 1998-04-01 | 2009-06-24 | 新日本石油株式会社 | Lubricant for condoms and condoms with the same |
DE19845305A1 (en) | 1998-10-01 | 2000-04-06 | Beiersdorf Ag | Active combination, useful in cosmetic and dermatological formulations, contains saturated fatty acid mono- and/or diglyceride esters partly neutralized with citric acid and flavone, flavanone and/or flavonoid |
US6312665B1 (en) | 1998-12-21 | 2001-11-06 | Generex Pharmaceuticals Incorporated | Aerosol formulations for buccal and pulmonary application |
US6436367B1 (en) | 1998-12-21 | 2002-08-20 | Generex Pharmaceuticals Inc. | Aerosol formulations for buccal and pulmonary application |
US6375975B1 (en) | 1998-12-21 | 2002-04-23 | Generex Pharmaceuticals Incorporated | Pharmaceutical compositions for buccal and pulmonary application |
JP2002537102A (en) | 1999-02-26 | 2002-11-05 | カイロン コーポレイション | Microemulsion with adsorbed polymer and fine particles |
US6350432B1 (en) | 1999-03-19 | 2002-02-26 | Generex Pharmaceuticals Incorporated | Pressurized container having an aerosolized pharmaceutical composition |
US6492326B1 (en) | 1999-04-19 | 2002-12-10 | The Procter & Gamble Company | Skin care compositions containing combination of skin care actives |
US7078050B2 (en) | 1999-06-01 | 2006-07-18 | Normajean Fusco | Composition for topical treatment |
US6896897B2 (en) | 1999-07-23 | 2005-05-24 | Alwyn Company, Inc. | Flexible applicator for applying oil-in-water emulsion with improved stability |
US6281236B1 (en) | 1999-07-23 | 2001-08-28 | Alwyn Company, Inc. | Oil-in-water emulsion with improved stability |
EP1116483B1 (en) | 1999-07-27 | 2010-12-08 | Shiseido Company Limited | Oil-in-water emulsion composition |
IL132625A (en) | 1999-10-28 | 2007-06-17 | Avi Dascalu | Composition for inducing hair growth |
FR2800605B1 (en) | 1999-11-08 | 2002-08-16 | Oreal | COMPOSITION CONTAINING AN AQUEOUS SUSPENSION OF ELASTOMERIC ORGANOPOLYSILOXANE PARTICLES, AND ITS COSMETIC USES |
JP2001197936A (en) | 2000-01-19 | 2001-07-24 | Fuairudo Kk | Improved method for hair styling |
JP3805159B2 (en) | 2000-01-25 | 2006-08-02 | ユニ・チャーム株式会社 | Absorbent articles containing skin protection ingredients |
JP2001316251A (en) | 2000-02-24 | 2001-11-13 | Fuairudo Kk | Squalane containing ultrafine particles of carbon combustion residue and method for producing the same |
FR2806260B1 (en) | 2000-03-20 | 2005-04-08 | Pharmascience Lab | USE OF A CONCENTRATED VEGETABLE OIL IN ITS UNPAINSIBLE FRACTION AS A FOOD INGREDIENT, PROCESS FOR THE PREPARATION OF SAID OIL, COMPOSITION OR FOOD SUPPLEMENT CONTAINING THE SAME |
US7297717B2 (en) | 2000-04-27 | 2007-11-20 | Kao Corporation | Emulsion cosmetic |
FR2808196A1 (en) | 2000-04-27 | 2001-11-02 | Andre Rougereau | NEW MEDICINES BASED ON MIXTURES OF SESQUITERPENES |
FR2808446B1 (en) | 2000-05-05 | 2004-12-03 | Seppic Sa | LATEX INVERTED ON WHITE MINERAL OILS, SQUALANE, POLYISOBUTENE HYDROGENE, ISOHEXADECANE OR ISODODECANE, COSMETIC OR PHARMACEUTICAL COMPOSITIONS COMPRISING |
FR2808447B1 (en) | 2000-05-05 | 2004-12-03 | Seppic Sa | REVERSE LATEX ON WHITE MINERAL OILS, SQUALANE OR HYDROGEN POLYISOBUTENE, COSMETIC, DERMOCOSMETIC, DERMOPHARMACEUTICAL OR PHARMACEUTICAL COMPOSITIONS INCLUDING |
WO2002007745A1 (en) | 2000-07-26 | 2002-01-31 | Yuuzou Tsuchida | Antipruritic compositions and compositions promoting wound healing |
IT1317890B1 (en) | 2000-08-03 | 2003-07-15 | Idi Irccs | PREPARATION TO BE USED AS A LIPID COMPONENT IN COSMETICS. |
IT1317911B1 (en) | 2000-09-28 | 2003-07-15 | Idi Irccs | COSMETIC FORMULATION. |
DE10048683A1 (en) | 2000-09-30 | 2002-04-11 | Beiersdorf Ag | Preparation of water-based emulsion type W / O based on low-viscosity, well-spreading lipid components, further containing one or more alkyl methicone copolyols and / or alkyl dimethicopolyols |
JP2002209788A (en) | 2001-01-16 | 2002-07-30 | Uni Charm Corp | Wet wiper |
WO2002058640A1 (en) | 2001-01-23 | 2002-08-01 | Harris Dennis H | Topical therapeutic skin care system |
US6471954B2 (en) | 2001-01-24 | 2002-10-29 | Cortex Technology Aps | Method for the production and use of a cream containing vitamin-A |
US6479040B1 (en) | 2001-02-06 | 2002-11-12 | Coty Inc. | Cosmetic formulation |
WO2002067874A1 (en) | 2001-02-28 | 2002-09-06 | Kao Corporation | Cosmetics |
TWI248369B (en) | 2001-02-28 | 2006-02-01 | Neopharm Co Ltd | Multi-lamellar emulsion for stabilizing dermatologically useful ingredients and external preparation utilizing the same |
US20030003069A1 (en) | 2001-04-04 | 2003-01-02 | Carson John C. | Multiple phase foaming personal cleansing products |
US20020155083A1 (en) | 2001-04-19 | 2002-10-24 | Morris Mann | Dermal regeneration methods and compositions related thereto in conjunction with laser phototherapy, microdermabrasion and epidermabrasion |
US6699464B1 (en) | 2001-07-30 | 2004-03-02 | Stiefel Laboratories, Inc. | Compositions for treatment of hyperpigmentation and methods for making and using such compositions |
JP3608537B2 (en) | 2001-08-17 | 2005-01-12 | 富士ゼロックス株式会社 | Resin powder for external composition for skin, skin cleanser and cosmetic using the same, and method for producing resin powder for external composition for skin |
FR2831442B1 (en) | 2001-10-30 | 2005-02-11 | Oreal | COSMETIC COMPOSITION MIMING THE SEBUM, AND USES THEREOF |
US20030093045A1 (en) | 2001-11-13 | 2003-05-15 | Erdman Carol L. | Absorbing article having zoned areas of hydrophilicity |
US20020048603A1 (en) | 2001-12-07 | 2002-04-25 | Fred Burmeister | Hydrogel composition |
CA2474058A1 (en) | 2002-01-25 | 2003-07-31 | Mariana De Oliveira | Composition for and method of treatment for skin ailments |
US7314634B2 (en) | 2002-02-22 | 2008-01-01 | Steven Hernandez | Use of polyphenols to treat skin conditions |
US20030165585A1 (en) | 2002-02-25 | 2003-09-04 | Mann Maria A. | Xanthine-containing compositions for oral administration and uses related thereto |
NZ535270A (en) | 2002-03-12 | 2006-11-30 | Univ Montreal | Composition having gelling properties for the sustained delivery of bioactive substances |
ITMI20020756A1 (en) | 2002-04-09 | 2003-10-09 | Sinclair Pharma S R L | TOPICAL PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF DERMATITIS |
DK1359247T3 (en) | 2002-04-30 | 2006-02-13 | Cognis Ip Man Gmbh | With microcapsules treated fibers and flat textile products |
US7959935B2 (en) | 2002-05-03 | 2011-06-14 | Children's Hospital Medical Center | Simulated vernix compositions for skin cleansing and other applications |
CA2485171A1 (en) | 2002-05-03 | 2003-11-13 | Children's Hospital Medical Center | Simulated vernix compositions for skin cleansing and other applications |
US8349301B2 (en) * | 2002-06-04 | 2013-01-08 | The Procter & Gamble Company | Shampoo containing a gel network |
DE10227409B4 (en) | 2002-06-14 | 2005-03-24 | Coty B.V. | Cosmetic gel product based on oils and copolymers |
US7906557B2 (en) | 2002-06-19 | 2011-03-15 | Maruha Nichiro Seafoods, Inc. | Oral preventive/therapeutic agent for skin damage containing diacylglyceryl ether |
JP5122060B2 (en) | 2002-06-25 | 2013-01-16 | 株式会社 資生堂 | Anti-aging agent |
KR100533458B1 (en) | 2002-07-20 | 2005-12-07 | 대화제약 주식회사 | Composition for solubilization of paclitaxel and preparation method thereof |
US20040016436A1 (en) | 2002-07-26 | 2004-01-29 | Charles Thomas | Adsorbents for smoking articles comprising a non-volatile organic compound applied using a supercritical fluid |
US20040185016A1 (en) | 2002-07-30 | 2004-09-23 | Popp Karl F | Compositions for treatment of hyperpigmentation and methods for making and using such compositions |
DE20214753U1 (en) | 2002-09-24 | 2002-12-12 | Hando Handels Ges. M.B.H., Graz | Pharmaceutical composition for the treatment and / or prevention of light eruption |
US20050276767A1 (en) | 2002-10-18 | 2005-12-15 | L'oreal | Composition containing an oily phase and a naphthopyran dye, cosmetic treatment processes |
EP1410784B1 (en) | 2002-10-18 | 2007-02-07 | L'oreal | Cosmetic composition comprising an oil phase and a naphthopyran dye and method |
US6723689B1 (en) | 2003-01-08 | 2004-04-20 | Becton Dickinson And Company | Emollient alcohol skin disinfecting formulation |
JP4791682B2 (en) | 2003-02-21 | 2011-10-12 | 帝國製薬株式会社 | Acupuncture treatment |
US20050025847A1 (en) | 2003-02-26 | 2005-02-03 | Program For Appropriate Technology In Health | Microbicidal compositions and method of use |
US20050031571A1 (en) | 2003-05-16 | 2005-02-10 | Khaiat Alain V. | Topical treatment of ingrown hairs |
DE10325158A1 (en) | 2003-05-28 | 2004-12-23 | Coty B.V. | Cosmetic for the remineralization and anti-aging treatment of the skin |
US6743760B1 (en) * | 2003-05-29 | 2004-06-01 | Colgate-Palmolive Company | Transparent conditioning shampoo |
EP1643966B1 (en) | 2003-06-17 | 2010-07-21 | Cognis IP Management GmbH | Modified soy proteins in skin tightening compositions |
US20050025817A1 (en) | 2003-07-03 | 2005-02-03 | Bhatia Kuljit S. | Delivery system for topical medications |
CN101090702B (en) | 2003-10-03 | 2011-06-08 | 宝洁公司 | Topical composition |
US20050089488A1 (en) | 2003-10-27 | 2005-04-28 | Kim Joo W. | Deodorant composition with monocyclic, unsaturated sequiterpene alcohols and glyceryl monoalkyl ethers as synergistic active deodorant agents |
GB0326520D0 (en) | 2003-11-13 | 2003-12-17 | Compton Developments Ltd | Molluscicidal and anti-barnacle compounds |
DE10359538A1 (en) | 2003-12-17 | 2005-07-14 | Hans Schwarzkopf & Henkel Gmbh & Co. Kg | Toning agent in tubes |
DE10359539A1 (en) | 2003-12-17 | 2005-07-14 | Hans Schwarzkopf & Henkel Gmbh & Co. Kg | Nurturing Oxidant in Tube |
US20050158262A1 (en) | 2003-12-19 | 2005-07-21 | Eric Parris | Cosmetic composition comprising a cationic agent, a polymer comprising a hetero atom and an oil, and cosmetic treatment process |
FR2863879B1 (en) | 2003-12-19 | 2006-02-03 | Oreal | COSMETIC COMPOSITION COMPRISING CATIONIC AGENT, SEMI-CRYSTALLINE POLYMER AND OIL AND METHOD OF COSMETIC TREATMENT |
DE102004007966A1 (en) | 2004-02-18 | 2005-09-08 | Merck Patent Gmbh | A topical composition containing at least one aryloxime and bisabolol |
DE202004002471U1 (en) | 2004-02-18 | 2004-04-22 | Wella Ag | Hair treatment agent with terpolymer of vinyl pyrrolidone, methacrylamide and vinyl imidazole and active ingredients |
US7829067B2 (en) | 2004-03-03 | 2010-11-09 | Bio-Botanica, Inc. | Method and composition for treating oral bacteria and inflammation |
GB0406037D0 (en) | 2004-03-18 | 2004-04-21 | Ici Plc | Metal oxide dispersion |
IL160950A (en) | 2004-03-18 | 2008-12-29 | Shlomo Navarro | Pest-impervious packaging material and pest-control composition |
DE102004017431A1 (en) | 2004-04-08 | 2005-10-27 | Wella Ag | Use of N-hydroxyalkyl-O-benzyl chitosans for hair treatment |
JP5041279B2 (en) | 2004-04-22 | 2012-10-03 | 株式会社 Mbr | Formulation containing bacterial cell wall skeleton component |
US7479289B2 (en) | 2004-07-02 | 2009-01-20 | Medicis Pharmaceutical Corporation | Stable cleanser compositions containing sulfur |
DE102004036092A1 (en) | 2004-07-24 | 2006-02-16 | Beiersdorf Ag | Skin and / or hair products containing compounds to increase the tanning of the skin |
FR2873573B1 (en) | 2004-08-02 | 2006-11-17 | Oreal | WATER-IN-OIL EMULSION COMPRISING NON-VOLATILE NON-SILICONE OIL, CATIONIC SURFACTANT, POLAR POLYOLEFIN (S), AND ALKYLMONOGLYCOSIDE OR ALKYLPOLYGLYCOSIDE |
US20060024258A1 (en) | 2004-08-02 | 2006-02-02 | L'oreal | Water-in-oil emulsion comprising a non-volatile non-silicone oil, cationic and nonionic surfactants, and an alkylmonoglycoside or alkylpolyglycoside |
US20060051310A1 (en) | 2004-08-02 | 2006-03-09 | L'oreal | Water-in-oil emulsion comprising a non-volatile non-silicone oil, a cationic surfactant, a polyolefin with polar portion(s), and an alkylmonoglycoside or alkylpolyglycoside |
FR2873572B1 (en) | 2004-08-02 | 2007-03-09 | Oreal | WATER-IN-OIL EMULSION COMPRISING NON-VOLATILE NON-SILICONE OIL, CATIONIC AND NON-IONIC SURFACTANTS, AND ALKYLMONOGLYCOSIDE OR ALKYLPOLYGLYCOSIDE |
KR101238703B1 (en) | 2004-08-03 | 2013-03-04 | 바이탈 헬스 사이언시즈 피티와이 리미티드 | Carrier for oral administration |
JP4758915B2 (en) | 2004-08-06 | 2011-08-31 | バイオスペクトラム,インコーポレイテッド | Multilamellar liposome and production method thereof |
EP1782801A4 (en) | 2004-08-27 | 2008-08-06 | Senju Pharma Co | Eyewash liquid for dry eye therapy |
DE102004042848A1 (en) | 2004-09-04 | 2006-03-09 | Wella Ag | Hair treatment composition containing a polymer combination |
JP4509898B2 (en) | 2004-09-07 | 2010-07-21 | 花王株式会社 | Wrinkle removal composition |
US20060062749A1 (en) | 2004-09-16 | 2006-03-23 | Shelton Michael C | personal care products incorporating cellulosic fatty acid esters |
DE102004062702A1 (en) * | 2004-09-16 | 2006-03-23 | Henkel Kgaa | Color-changing agents with Moringa extract |
GB0424891D0 (en) * | 2004-11-11 | 2004-12-15 | Boots Co Plc | Topical compositions |
DE602005013422D1 (en) | 2004-11-22 | 2009-04-30 | Symrise Gmbh & Co Kg | FORMULATIONS WITH CERAMIDES AND / OR PSEUDOCERAMIDES AND (ALPHA-) BISABOLOL FOR THE TREATMENT OF SKIN DAMAGE |
DE102005004704A1 (en) | 2005-02-02 | 2006-08-10 | Goldschmidt Gmbh | Guanidino group-containing siloxanes and their use for cosmetic formulations |
DE102005028385A1 (en) | 2005-06-20 | 2006-12-28 | Wella Aktiengesellschaft | Product release system, useful to atomize a cosmetic composition for hair treatment, has pressure-resistant packaging; a spray head containing a capillary; and a propellant-containing cosmetic composition |
DE102005028383A1 (en) | 2005-06-20 | 2006-12-28 | Wella Aktiengesellschaft | Product release system for atomizing cosmetic composition for hair comprises pressure-resistant packaging; spray head containing capillary; and propellant-containing cosmetic composition including polymer |
US20090098079A1 (en) * | 2005-06-20 | 2009-04-16 | The Procter & Gamble Company | Product release system for atomizing cosmetic hair compositions containing cationic polymers |
IL169525A (en) | 2005-07-04 | 2008-12-29 | Fischer Farmaceuticals Ltd | Non-discolored sterile wipe and process for its preparation |
US8703095B2 (en) | 2005-07-07 | 2014-04-22 | Sanofi Pasteur S.A. | Immuno-adjuvant emulsion |
US7744856B2 (en) | 2005-10-03 | 2010-06-29 | Biotech Research And Development Corporation | Formulations with feruloyl glycerides and methods of preparation |
WO2007042472A1 (en) | 2005-10-14 | 2007-04-19 | Symrise Gmbh & Co. Kg | Synergistic mixtures of bisabolol and ginger extract |
US20080171030A1 (en) | 2005-11-01 | 2008-07-17 | Juice Beauty | Compositions for juice-based moisturizers |
ES2275435B1 (en) | 2005-11-18 | 2008-06-01 | Farmaleis, S.L. | "PHARMACEUTICAL COMPOSITION THAT INCLUDES SCALLENE AND USE OF THE SAME FOR THE PREPARATION OF A MEDICINAL PRODUCT FOR THE TREATMENT OF CANCER. |
US20070154439A1 (en) | 2006-01-04 | 2007-07-05 | Paula Dorf | Cosmetic composition for use around the eyes |
FR2896162B1 (en) | 2006-01-13 | 2008-02-15 | Sanofi Pasteur Sa | EMULSION OIL IN THERMOREVERSIBLE WATER |
CA2936822C (en) | 2006-01-19 | 2021-09-14 | Mary Kay, Inc. | Skin care compositions comprising kakadu plum extract |
US20100008880A1 (en) | 2006-05-03 | 2010-01-14 | John Castro | Clear Cosmetic Compositions And Methods Of Using |
EP2295033B1 (en) | 2006-05-11 | 2019-04-10 | Evonik Degussa GmbH | Cosmetic compositions containing side chain crystalline (scc) polymers |
JP5207426B2 (en) | 2006-06-30 | 2013-06-12 | 学校法人神奈川大学 | Cosmetics and method for producing the same |
JP5342102B2 (en) | 2006-07-04 | 2013-11-13 | 昭和電工株式会社 | Emulsion composition |
FR2904554B1 (en) | 2006-08-04 | 2010-11-05 | Zheng Xu | CYTOTROPIC HETEROGENEOUS MOLECULAR LIPIDS (LMHC), PREPARATION METHOD, AND METHODS FOR TREATMENT OF PATIENTS CARRYING MULTIPLE CANCERS |
JP5132109B2 (en) | 2006-09-01 | 2013-01-30 | 花王株式会社 | One-part hair dye composition |
US8158144B2 (en) | 2006-09-15 | 2012-04-17 | Calvin Garris | Hair care solution protecting natural hair from gluing products |
US7845360B2 (en) | 2006-10-27 | 2010-12-07 | Goody Products, Inc. | Therapeutic styling brush with infusion delivery |
US7832413B2 (en) | 2006-10-27 | 2010-11-16 | Goody Products, Inc. | Therapeutic styling brush with infusion delivery |
GB0622282D0 (en) | 2006-11-08 | 2006-12-20 | Novartis Ag | Quality control methods |
US20080175931A1 (en) | 2007-01-19 | 2008-07-24 | Nathalie Schlemer | Cosmetic foundation |
US20080175805A1 (en) | 2007-01-19 | 2008-07-24 | Guthy-Renker Corporation | Cosmetic foundation |
PL2120845T3 (en) | 2007-02-21 | 2013-03-29 | Rovi Cosmetics Int Gmbh | Nanoparticles for use in cosmetic and dermatological formulations |
EP2134337A4 (en) | 2007-02-22 | 2011-11-09 | Healing Skin Llc | Novel burn treatment composition |
KR101481197B1 (en) | 2007-05-24 | 2015-01-09 | 로더스 크로클란 비.브이. | Process for producing compositions comprising tocopherols and tocotrienols |
US20080305057A1 (en) | 2007-06-07 | 2008-12-11 | Damage Control Technologies, Inc. | New and improved skin treatment systems |
WO2009010883A2 (en) | 2007-07-03 | 2009-01-22 | L'oreal | Methods and kits for permanently coloring hair |
DE102007037783A1 (en) | 2007-08-10 | 2009-02-19 | Cognis Ip Management Gmbh | Lipophilic preparations |
US20090074700A1 (en) | 2007-09-14 | 2009-03-19 | L'oreal | Compositions and methods for imparting shine onto hair |
US9968535B2 (en) * | 2007-10-26 | 2018-05-15 | The Procter & Gamble Company | Personal care compositions comprising undecyl sulfates |
JP2011503192A (en) | 2007-11-13 | 2011-01-27 | プレスパース、エルエルシー | Silicon-free hydrocarbons that impart texture and volatility |
US20090130220A1 (en) | 2007-11-20 | 2009-05-21 | Johnson Pamela A | Cosmetic composition having pomace olive oil |
EP2224908B1 (en) * | 2007-11-30 | 2017-11-01 | Galderma Research & Development | Compositions containing at least one naphthoic acid derivative, benzoyl peroxide and at least one film-forming agent, methods for preparing same and uses thereof |
DE102008006394A1 (en) | 2008-01-28 | 2009-07-30 | Beiersdorf Ag | Use of active ingredient complexes of panthenol, glycerol, citrate and / or bisabolol against pollen allergies |
ES2325243B1 (en) * | 2008-02-27 | 2011-05-04 | Universidad De Granada | RECOMBINANT ANTIGEN. |
US20090238905A1 (en) * | 2008-03-20 | 2009-09-24 | Symrise, Inc. | Inflammation reducing action of synergistic mixtures of bisabolol and ginger extracts |
DE102008002707A1 (en) | 2008-06-27 | 2009-12-31 | Evonik Goldschmidt Gmbh | Hair treatment compositions and hair aftertreatment agents for protection against damage caused by chemical treatment and for repairing damaged hair already containing etherguanidines as active substances |
JP5368021B2 (en) | 2008-07-16 | 2013-12-18 | 株式会社ダイセル | Cleansing cosmetics |
JP5670903B2 (en) | 2008-08-29 | 2015-02-18 | ロレアル | Method and kit for permanently coloring hair using a color former composition comprising an oxidant composition and a shampoo |
EP2161015A1 (en) * | 2008-09-05 | 2010-03-10 | KPSS-Kao Professional Salon Services GmbH | Conditioning composition for hair |
EP2218447B1 (en) | 2008-11-04 | 2017-04-19 | PharmaSol GmbH | Compositions containing lipid micro- or nanoparticles for the enhancement of the dermal action of solid particles |
FR2939039B1 (en) | 2008-12-01 | 2010-12-31 | Basf Beauty Care Solutions France Sas | NEW SEBUM SECRET INHIBITOR AGENT |
EA020844B1 (en) | 2009-02-25 | 2015-02-27 | Стифел Рисерч Оустрэйлиа Пти Лтд. | FOAMING COMPOSITION FOR LOCAL APPLICATION |
CN101485622A (en) * | 2009-03-03 | 2009-07-22 | 张嘉恒 | Shampoo containing extract of Moringa oleifera and preparation method thereof |
JP5724108B2 (en) | 2009-04-22 | 2015-05-27 | メドスキン ソリューションズ ドクター ズベラック アーゲーMedSkin Solutions Dr.Suwelack AG | Lyophilized composition |
US8871190B2 (en) | 2009-04-25 | 2014-10-28 | Sergeant's Pet Care Products, Inc. | Polymeric pheromone formulation and method of use to calm stress-related behavior in mammals over an extended period of time |
US8911774B2 (en) | 2009-05-18 | 2014-12-16 | Cellhealth Technologies Ltd. | Topical composition for anti-aging skin treatment using dual DNA repair mechanism and method of use |
DK177144B1 (en) | 2009-06-19 | 2012-02-06 | Aquaporin As | A liquid membrane suitable for water extraction |
BRPI0925099A2 (en) | 2009-06-24 | 2018-10-16 | Strategic Science & Tech Llc | topical composition containing ibuprofen |
US9155915B2 (en) | 2009-07-27 | 2015-10-13 | Dermadoctor, Inc. | Moisturizing retinol composition |
CA2770920C (en) | 2009-08-12 | 2014-07-22 | Colgate-Palmolive Company | Oral care composition |
EP2286785A1 (en) | 2009-08-20 | 2011-02-23 | Kneipp-Werke Kneipp-Mittel-Zentrale GmbH & Co. KG | Compound for cleaning and/or care of skin with an ethanolic-aqueous hydro-dispersible mint composition |
US20110112041A1 (en) | 2009-10-01 | 2011-05-12 | Baylor Research Institute | Treatment of Male-Pattern Baldness by Local Induction of the Metabolic Defect of Fabry Disease |
WO2011056226A1 (en) | 2009-11-05 | 2011-05-12 | Mercia Pharma Llc | Adjuvanted nanoparticulate influenza vaccine |
JP5174789B2 (en) | 2009-11-25 | 2013-04-03 | 花王株式会社 | O / W emulsified cosmetic |
JP5149886B2 (en) | 2009-11-25 | 2013-02-20 | 花王株式会社 | W / O emulsified cosmetic |
MX360299B (en) | 2009-12-03 | 2018-10-29 | Novartis Ag | Circulation of components during homogenization of emulsions. |
US8337870B2 (en) | 2009-12-15 | 2012-12-25 | Young Pharmaceuticals, Inc. | Low toxicity topical active agent delivery system |
FR2953716B1 (en) * | 2009-12-16 | 2015-03-27 | Oreal | KIT FOR FORMULATING A COSMETIC PRODUCT |
JP4863411B2 (en) | 2010-01-29 | 2012-01-25 | 株式会社 資生堂 | Oil-in-water emulsified sunscreen cosmetics |
EP2531219A4 (en) | 2010-02-05 | 2015-01-14 | Phosphagenics Ltd | SUPPORT COMPOSITION |
JP5578880B2 (en) | 2010-02-25 | 2014-08-27 | 株式会社アライアンス | Anti-malassezia agent |
US20120201857A1 (en) | 2010-03-17 | 2012-08-09 | Pankaj Modi | Transdermal delivery system for therapeutics |
US8623330B2 (en) | 2010-03-18 | 2014-01-07 | Precision Dermatology, Inc. | Emollient foams for treatment of seborrheic dermatitis |
EP2569278B1 (en) | 2010-05-14 | 2018-10-10 | David J. Schneider | Low chlorine odor control compositions |
JP2011246361A (en) * | 2010-05-24 | 2011-12-08 | Kao Corp | Hair cosmetic |
IT1402847B1 (en) | 2010-06-01 | 2013-09-27 | Color Cosmetics S R L | COMPACT SOLID POWDERED COSMETIC PRODUCT AND ITS OBTAINING PROCESS. |
US20110305737A1 (en) | 2010-06-09 | 2011-12-15 | NY Derm LLC | Multi-Active Microtargeted Anti-Aging Skin Cream Polymer Technology |
GB201009673D0 (en) | 2010-06-10 | 2010-07-21 | Glaxosmithkline Biolog Sa | Novel process |
JP5666837B2 (en) | 2010-06-29 | 2015-02-12 | 花王株式会社 | Nanofiber sheet |
WO2012011904A1 (en) | 2010-07-22 | 2012-01-26 | The Procter & Gamble Company | Methods for improving the appearance of hyperpigmented spot(s) using an extract of laminaria saccharina |
BR112013007955B1 (en) | 2010-10-05 | 2018-08-07 | Lubrizol Advanced Materials, Inc. | TENSIVE COMPOSITION, PERSONAL CARE CLEANING COMPOSITION, AND METHOD FOR THICKING A WATER TENSIVE |
US8361520B2 (en) | 2010-10-08 | 2013-01-29 | Palmer Debbie M | Antioxidant skin care compositions |
CN103298519B (en) | 2010-11-12 | 2016-09-14 | 犹他大学研究基金会 | Intravaginal device for the transmission of controlled type lubricant |
CA2818083A1 (en) | 2010-11-15 | 2012-05-24 | Sanofi Pasteur Limited | Immunogenic compositions |
EP2648809B1 (en) | 2010-12-09 | 2019-04-03 | Y&B Mother's Choice Ltd. | Natural formulations |
WO2012076352A1 (en) | 2010-12-09 | 2012-06-14 | Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. | Composition for topical use for treating skin disorders |
US9249429B2 (en) | 2010-12-09 | 2016-02-02 | University Of Tsukuba | Microorganism having high squalene-producing ability, and method for producing squalene by means of same |
US8476316B2 (en) | 2010-12-15 | 2013-07-02 | Olatec Industries Llc | 3-methanesulfonylpropionitrile for treating inflammation and pain |
US20140004177A1 (en) | 2010-12-29 | 2014-01-02 | Strategic Science & Technologies, Llc | Cox-2 inhibitors and related compounds, and systems and methods for delivery thereof |
EP2658564A4 (en) | 2010-12-29 | 2015-01-14 | Strategic Science & Tech Llc | Methods and systems for treatment of migraines and other indications |
EP4491225A3 (en) | 2010-12-29 | 2025-03-26 | Strategic Science & Technologies, LLC | Treatment of erectile dysfunction and other indications |
CN103429246A (en) | 2010-12-29 | 2013-12-04 | 战略科学与技术有限责任公司 | Transdermal delivery of treatments for fungal infections and other indications |
CN103442723A (en) | 2010-12-29 | 2013-12-11 | 战略科学与技术有限责任公司 | Systems and methods for treating allergy and other indications |
US9011828B2 (en) * | 2011-01-25 | 2015-04-21 | Elc Management, Llc | Compositions and methods for permanent straightening of hair |
US8871811B2 (en) | 2011-02-07 | 2014-10-28 | Professional Compounding Centers of America, Ltd | Permeation enhancers for topical formulations |
US9532969B2 (en) | 2011-02-08 | 2017-01-03 | The William M. Yarbrough Foundation | Method for treating psoriasis |
GB2502029B (en) * | 2011-02-09 | 2018-02-21 | Forward Scout Entpr Pty Ltd | Cosmetic or pharmaceutical formulation comprising hyaluronate crosspolymer and one or more of; azelaic acid, or derivative, and natural oils |
US9119974B2 (en) | 2011-03-04 | 2015-09-01 | Ahmed H. Al-Qahtani | Skin cream |
US8846061B1 (en) | 2011-03-08 | 2014-09-30 | Mark S. Bezzek | Multivitamin-mineral regimens for longevity and wellness |
US9789042B2 (en) | 2011-03-25 | 2017-10-17 | Kokyu Alcohol Kogyo Co., Ltd. | Damaged hair improving agent and process for improving damaged hair using the same |
WO2012145258A1 (en) | 2011-04-18 | 2012-10-26 | Pop Test Cortisol Llc | Hair loss treatment |
US20130231317A1 (en) | 2011-07-19 | 2013-09-05 | Michael S. Riepl | Dhea bioadhesive controlled release gel |
US8506938B2 (en) | 2011-08-26 | 2013-08-13 | Hsien-Wen Lin | Compound applying to skin and a method making the same |
US9446089B1 (en) | 2011-09-20 | 2016-09-20 | Aja Henderson | Oil blend for skin treatment |
US9320744B2 (en) | 2011-10-19 | 2016-04-26 | Dhea Llc | DHEA bioadhesive controlled release gel |
WO2013065051A1 (en) | 2011-11-01 | 2013-05-10 | Naveh Pharma (1996) Ltd. | Formulation and device for treating ceruminosis |
US9295622B2 (en) | 2011-12-06 | 2016-03-29 | Mary Kay Inc. | Substantive sunscreen formulation |
EP2604298B1 (en) | 2011-12-15 | 2016-03-30 | DEMO SA Pharmaceutical Industry | Multipurpose solutions for contact lens care comprising chamomile |
FR2984116B1 (en) | 2011-12-19 | 2014-08-22 | Oreal | KERATIN FIBER OXIDATION COLORING COMPOSITION COMPRISING PARTICULATE FATTY ALCOHOLS, A LIQUID FATTY BODY, AND A CATIONIC POLYMER |
US20130156708A1 (en) * | 2011-12-20 | 2013-06-20 | Symrise Ag | Phenol derivatives as antimicrobial agents |
ES2378028B1 (en) | 2012-02-22 | 2013-02-18 | Ignacio Umbert Millet | Cosmetic composition for skin rejuvenation and corresponding procedure and uses |
US20130224268A1 (en) | 2012-02-27 | 2013-08-29 | Newgen Biopharma Corp. | Topical delivery of hormonal and non hormonal nano formulations, methods of making and using the same |
EP2641584A1 (en) | 2012-03-19 | 2013-09-25 | Coty Germany GmbH | Cosmetic skin composition with soothing effect and its use |
EP2641585A1 (en) | 2012-03-19 | 2013-09-25 | Coty Germany GmbH | Cosmetic skin composition with soothing effect and its use |
US8617579B2 (en) | 2012-04-16 | 2013-12-31 | Conopco, Inc. | Pre-blended mixtures of specific naturally sourced liquid materials structured with naturally sourced high melting point structuring material |
EP2838630A2 (en) | 2012-04-16 | 2015-02-25 | Roquette Frères | Method for refining squalene produced by microalgae |
BR102012009350B1 (en) | 2012-04-20 | 2020-12-29 | Biolab Sanus Farmacêutica Ltda | topical pharmaceutical composition, production process of the topical pharmaceutical composition and use of the topical pharmaceutical composition |
CA2783146C (en) | 2012-05-08 | 2020-04-07 | Advanced Bionutrition Corp. | Compositions and methods for encapsulating vaccines for the oral vaccination and boostering of fish and other animals |
JP5302472B1 (en) | 2012-05-17 | 2013-10-02 | 英司 佐久間 | Spray-type pet animal composition |
FR2991337B1 (en) | 2012-05-29 | 2016-09-02 | Roquette Freres | CONTINUOUS PROCESS FOR ENRICHING DHA WITH ETHYL ESTERS OF AN OIL PRODUCED BY MICROALGUES |
EP2885054A1 (en) | 2012-08-16 | 2015-06-24 | Gencor Armats Biotek Pvt. Ltd | Herbal preparation for stimulation of hair growth, control of hair fall, dandruff and infections thereof using ageratum spp. |
US9399009B1 (en) | 2012-10-05 | 2016-07-26 | Clark Pharmaceuticals, Llc | Composition and method of treating skin conditions |
DE102012218733A1 (en) | 2012-10-15 | 2014-04-17 | Beiersdorf Ag | Cosmetic or dermatological preparation for the prophylaxis and / or treatment of atopic dermatitis |
WO2014071354A1 (en) | 2012-11-05 | 2014-05-08 | Hercules Incorporated | Composition comprising conditioning and/or styling polymer |
ITBO20120631A1 (en) | 2012-11-19 | 2014-05-20 | Vi Rus Srl | COMPOSITION OF A DETERGENT FOAM BASED ON NATURAL EXTRACTS FOR CLEANSING THE PERIANAL AREA. |
CA2891204C (en) | 2012-12-03 | 2020-07-07 | Colgate-Palmolive Company | Compositions and methods for treating dental caries |
FR2999079B1 (en) * | 2012-12-11 | 2015-04-24 | Isp Investments Inc | COSMETIC USE OF A CARROT GERM EXTRACT AS A SLIMMING ACTIVE AGENT |
DE102012222956A1 (en) * | 2012-12-12 | 2014-06-12 | Beiersdorf Ag | Cosmetic preparations with yield point |
US8697043B1 (en) | 2013-01-08 | 2014-04-15 | Chattem, Inc. | Odor suppression of volatile organic analgesic compounds and method of use |
FR3002845B1 (en) | 2013-03-06 | 2015-04-03 | Oleos | COSMETIC AND / OR DERMATOLOGICAL PRODUCT BASED ON A CORK EXTRACT, AT LEAST ONE PART OF THE TREE PROVIDING THE CORK, AND AT LEAST ONE NATURAL FATTY BODY, ITS PREPARATION METHOD AND COMPOSITE |
WO2014159688A1 (en) | 2013-03-14 | 2014-10-02 | Sc Laboratories, Inc. | Bioactive concentrates and uses thereof |
US20140271923A1 (en) | 2013-03-14 | 2014-09-18 | Christopher Brian Reid | Compositions & formulations for preventing and treating chronic diseases that cluster in patients such as cardiovascular disease, diabetes, obesity, polycystic ovary syndrome, hyperlipidemia and hypertension, as well as for preventing and treating other diseases and conditions |
JP2016513690A (en) | 2013-03-15 | 2016-05-16 | ストラテジック サイエンス アンド テクノロジーズ, エルエルシー | Transdermal delivery of sildenafil and other phosphodiesterase 5 inhibitors |
EP2900207A1 (en) | 2013-03-15 | 2015-08-05 | The Procter & Gamble Company | Cosmetic compositions and methods for inhibiting melanin synthesis |
JP6300897B2 (en) | 2013-03-15 | 2018-03-28 | マース インコーポレーテッドMars Incorporated | Compositions and methods for preventing, reducing, alleviating or treating idiopathic vomiting |
AU2014234316B2 (en) | 2013-03-19 | 2018-09-27 | Biotech Tools S.A. | Allergen preparation |
US9907750B2 (en) | 2013-03-19 | 2018-03-06 | Senju Pharmaceutical Co., Ltd. | Two-layer separation-type eye drop containing squalane |
ITVR20130081A1 (en) | 2013-04-05 | 2014-10-06 | Fuber Ltd | EMULSIFYING ADDITIVE FOR THE FORMATION OF WATER EMULSIONS IN PURE FUEL OIL OR IN MIXTURES CONTAINING MAINLY FUEL OIL AND METHOD FOR ITS PRODUCTION |
US20140314911A1 (en) | 2013-04-18 | 2014-10-23 | Shandong Shenghai Health Care Products Co., Ltd. | Deep-Sea Fish Oil Capsule and its Preparation Method |
BR102013010477A2 (en) | 2013-04-29 | 2015-11-17 | Brasil Bio Fuels S A | Acetal esters produced from purified glycerin for use and applications such as emollients, lubricants, plasticizers, solvents, coalescents, humectants, polymerization monomers, biofuel additives |
WO2014179520A1 (en) | 2013-05-01 | 2014-11-06 | The Procter & Gamble Company | Cosmetic compositions and methods for inhibiting melanin synthesis |
US20140348873A1 (en) | 2013-05-22 | 2014-11-27 | Professional Compounding Centers Of America | Urea-Silicone Gel for Hyperkeratosis Treatment |
WO2015030702A2 (en) | 2013-08-26 | 2015-03-05 | Keith Desanto | High purity rhamnolipid cosmetic application |
HK1223548A1 (en) | 2013-08-30 | 2017-08-04 | 因温特国际有限公司 | Methods for the separation or purification of vitamin e, tocopherols and tocotrienols from lipid mixtures |
EP2842607B1 (en) | 2013-09-02 | 2018-05-30 | Symrise AG | A skin and/or hair whitening mixture |
US10774288B2 (en) | 2013-09-18 | 2020-09-15 | The Werc Shop, LLC | Terpene-based compositions, processes, methodologies for creation and products thereby |
US20150086522A1 (en) | 2013-09-23 | 2015-03-26 | Michael Todd True Organics Lp | Formulation containing herb infused aloe |
US8808759B1 (en) | 2013-09-25 | 2014-08-19 | Chattem, Inc | Stabilized colloidal preparations, pre-mix and process for preparing skin care compositions, improved skin care composition, method for treating the skin |
WO2015043931A1 (en) | 2013-09-25 | 2015-04-02 | Unilever Plc | Method for evaluating the lubrication and/or friction of hair |
TW201601629A (en) | 2013-10-02 | 2016-01-16 | Kyoyu Agri Co Ltd | Composition comprising harmful arthropod-attracting substance formed from plant-derived components and analogs thereof |
WO2015050316A1 (en) | 2013-10-04 | 2015-04-09 | 박성율 | Skin enhancement method and system comprising six steps |
US20160279073A1 (en) | 2013-10-31 | 2016-09-29 | Full Spectrum Laboratories, Ltd. | Terpene and cannabinoid formulations |
GB2520326A (en) * | 2013-11-15 | 2015-05-20 | Emma Neame | Composition |
US9801900B2 (en) | 2013-11-22 | 2017-10-31 | Mary Kay Inc. | Compositions for sensitive skin |
EP3074005A2 (en) | 2013-11-25 | 2016-10-05 | Unigroup ApS | Composition for dermatitis |
ITRM20130652A1 (en) | 2013-11-26 | 2015-05-27 | Aboca Spa Societa Agricola | NEW FRACTIONS OF CHAMOMILE EXTRACTS AND THEIR USES |
IL229836A0 (en) | 2013-12-08 | 2014-03-31 | Y & B Mother S Choice Ltd | Preparations for suppressing or attenuating ocular irritancy |
RU2678226C1 (en) | 2013-12-17 | 2019-01-24 | Саймон Фрейзер Юниверсити | Compounds, compositions and methods for attracting and/or arresting bed bugs |
US20150177221A1 (en) | 2013-12-19 | 2015-06-25 | L'oreal | Simulated contaminated skin formulation |
CN110251438A (en) | 2013-12-20 | 2019-09-20 | 辉瑞大药厂 | Pre-moistened wipes for the treatment of anorectal irritation and disorders |
WO2015095451A1 (en) | 2013-12-20 | 2015-06-25 | Metabolon, Inc. | Biomakers of de novo lipogenesis and methods using the same |
WO2015101809A1 (en) | 2013-12-31 | 2015-07-09 | Universidad De La Frontera | Fungicidal composition for controlling phytopathogenic diseases, comprising a mixture of the volatile compounds ethanol, 3-methylbutanol, isobutyl acetate, isoamyl acetate and alpha-bisabolol, and the use thereof for inhibiting the growth of the pathogenic fungus botrytis cinerea |
US20150182448A1 (en) | 2013-12-31 | 2015-07-02 | Shang Chen Mei Bang (Beijing) Biotechnology Co., Ltd. | Traditional chinese medicine composition for dispelling wringles and black eye and its preparation method |
US9237993B2 (en) * | 2014-01-24 | 2016-01-19 | Combe Incorporated | Gradual haircolor compositions and methods of using the same |
US9056065B1 (en) | 2014-01-27 | 2015-06-16 | Shawnee Green-Tucker | Hair composite |
FR3017048B1 (en) | 2014-02-06 | 2017-05-05 | Robertet Sa | NEW USE OF PERFUMERY COMPOUNDS AGAINST HAIR REPELLENT |
FR3017288B1 (en) | 2014-02-10 | 2019-06-07 | Bbr | COSMETIC COMPOSITION SUITABLE FOR MODIFYING THE COLOR OF KERATIN FIBERS, IN PARTICULAR HAIR |
WO2015121102A1 (en) | 2014-02-13 | 2015-08-20 | Basf Se | Capryloyl alanine ethylester as a penetration enhanceer |
BE1022714A1 (en) | 2014-03-17 | 2016-08-23 | Glaxosmithkline Biologicals Sa | OIL MIXTURES / SURFACTANT FOR SELF-EMULSIFICATION |
US20150265526A1 (en) | 2014-03-19 | 2015-09-24 | Beaute Pacifique Aps | Topical composition for the cosmetic treatment of the human skin |
WO2015164290A1 (en) | 2014-04-23 | 2015-10-29 | The Procter & Gamble Company | Cosmetic compositions having reduced irritation |
EP3137039B1 (en) | 2014-05-02 | 2020-08-12 | Hercules LLC | Personal care composition for a keratin substrate comprising conditioning and/or styling cationic tetra polymer |
CN104013955B (en) | 2014-06-18 | 2016-02-24 | 中国科学院过程工程研究所 | A kind of not containing O/w emulsion and uses thereof of surfactant |
US20160000682A1 (en) | 2014-07-02 | 2016-01-07 | Geoffrey Brooks Consultants Llc | Peptide-Based Compositions and Methods of Use |
DE202014106007U1 (en) | 2014-07-22 | 2015-07-23 | Bio.Lo.Ga. S.R.L. | A composition for use in the prevention and treatment of allergic rhinitis |
GB201413216D0 (en) | 2014-07-25 | 2014-09-10 | Croda Internat Plc And Sederma Sas | Anti-Dandruff Composition |
EA035556B1 (en) | 2014-07-25 | 2020-07-07 | Биосинз С.Р.Л. | Glycoconjugate vaccines comprising basic units of a molecular construct expressing built-in multiple epitopes for the formulation of a broad-spectrum vaccine against infections due to enteropathogenic bacteria |
CL2014002248A1 (en) | 2014-08-25 | 2014-10-17 | Muciderm S A | Pharmaceutical composition comprising snail drool helix aspersa müller (5% to 50%), chamomile extract (5% to 10%) and honey (5% to 10%); preparation procedure; use of the composition because it serves to prepare a medicament or device useful for preventing or treating lesions derived from psoriasis. |
CN106999512A (en) | 2014-09-18 | 2017-08-01 | 葛兰素史克消费保健(美国) 控股有限责任公司 | new preparation |
WO2016057615A1 (en) | 2014-10-08 | 2016-04-14 | Alva-Amco Pharmacal Companies, Inc. | Composition for nap promotion |
CL2014002729A1 (en) | 2014-10-10 | 2014-12-19 | Muciderm S A | Pharmaceutical composition consisting of snail drool helix aspersa müller (20-50%), chamomile extract (1-4%), propolis (1-4%) and additives and / or excipients, with a viscosity of 10 to 1000 pa- s, in the form of lotion, cream, soap or gel; procedure to obtain it; and its use to prevent or treat pathologies of rosacea. |
EP3209294B1 (en) | 2014-10-22 | 2019-08-21 | BIO.LO.GA. S.r.l. | Pharmaceutical composition for use in increasing the trophism of nasal mucosa |
US9855346B2 (en) | 2014-11-06 | 2018-01-02 | Chang Gung University Of Science And Technology | Fluorescent dye compositions and uses thereof |
US9827176B2 (en) | 2014-11-17 | 2017-11-28 | Shirley Johnson | Antifungal deodorant |
US9295632B1 (en) | 2014-12-17 | 2016-03-29 | L'oreal | Compositions comprising latex polymers and methods for altering the color of hair |
US20160175238A1 (en) | 2014-12-19 | 2016-06-23 | L'oreal | Hair cosmetic composition containing a polyurethane latex polymer and a silicone-organic polymer compound |
WO2016112201A1 (en) | 2015-01-07 | 2016-07-14 | Strategic Science & Technologies, Llc | Techniques and systems for transdermal delivery involving treatment of psoriasis, skin cancer, and other indications |
US9782333B2 (en) | 2015-01-21 | 2017-10-10 | Chattem Inc. | Oral composition for xerostomia |
EP3265177B1 (en) | 2015-01-22 | 2023-06-14 | Grey Pacific Labs, LLC | Formulations of hydrophilic compounds |
AU2016225026A1 (en) | 2015-02-27 | 2017-09-07 | Canopy Growth Corporation | Compositions comprising combinations of purified cannabinoids, with at least one flavonoid, terpene, or mineral |
WO2016144675A1 (en) | 2015-03-06 | 2016-09-15 | Medimmune, Llc | Vaccine dose and use thereof |
US20160317480A1 (en) | 2015-04-28 | 2016-11-03 | Nicholas Adam Brockman | Composition and Method of Pain Relief, Reduction of Inflammation, Maintenance of Joints, and Soothing Muscle Soreness |
US20160324914A1 (en) | 2015-05-05 | 2016-11-10 | Tocol Pharmaceuticals, Llc | Use of rice bran oil distillate extract for prevention and mitigation of the effects of radiation |
US10111823B2 (en) | 2015-05-06 | 2018-10-30 | Getco Llc | Shave cream formulation |
MX2017014683A (en) | 2015-05-18 | 2018-03-14 | Perry Thrower Angelo | Hair regrowth treatment and growth stimulant. |
WO2016196989A1 (en) | 2015-06-03 | 2016-12-08 | Senju Usa, Inc. | Topical composition |
ITUB20151795A1 (en) | 2015-07-02 | 2017-01-02 | Alfa Parf Group Spa | METHOD FOR COLORING KERATINIC FIBERS |
WO2017037534A1 (en) | 2015-09-06 | 2017-03-09 | Prestigio Ltd. | Topical compositions for treatment of psoriasis |
WO2017059136A1 (en) | 2015-10-02 | 2017-04-06 | Amyris, Inc. | Compositions containing bio-based farnesene or compounds derived therefrom and their use in consumer and industrial products |
US10286035B2 (en) | 2015-10-14 | 2019-05-14 | Paul Gavaris | Ophthalmic treatment composition and vehicle for delivery of pharmaceutical substances or therapeutic agents |
ITUB20155388A1 (en) | 2015-10-20 | 2017-04-20 | Codex V Srl | UNSAPONIFIABLE OF NATURAL LIPIDS FOR THE TREATMENT AND RE-BALANCING OF THE STEROID SCALE AFFECTED BY PERMANENT ALTERATION |
KR101647736B1 (en) | 2015-10-23 | 2016-08-11 | (주)씨앤씨인터내셔널 | Long-lasting powder essence composition having improved coloring and the feeling of use and the manufacturing method thereof |
US20170119658A1 (en) | 2015-11-01 | 2017-05-04 | Justin Turvey | Preparation for enhanced fingerprint image formation on a transparent surface of a live scan device |
US9968546B2 (en) | 2015-11-10 | 2018-05-15 | Vincent C Giampapa | Topical composition for skin treatment to reduce lines and wrinkles of the face and body using a dual DNA repair mechanism to address damage caused by aging and ultra-violet induced damage to the skin with combination of skin turgor enhancement compounds |
US10765617B2 (en) | 2015-11-20 | 2020-09-08 | Isp Investments Llc | Personal care compositions comprising copolymers of cationic monomers and acryloyl lactam based monomers, process for the same and method of use |
CN109562042B (en) | 2016-03-14 | 2023-02-21 | Isp投资有限公司 | A personal care composition comprising conditioning, color care and styling polymers for keratinous substrates |
MX2018011348A (en) | 2016-03-18 | 2019-07-12 | Brian Reid Christopher | COMPOSITIONS OF NATURAL EXTRACTS AND USE OF THE SAME TO PREVENT OR TREAT DISEASES. |
ITUA20161870A1 (en) | 2016-03-21 | 2017-09-21 | Cristiano Ravetta | SPRAY DISPENSER AND COMPOSITION DEVICE FOR TOPIC APPLICATION |
US10231911B2 (en) | 2016-03-31 | 2019-03-19 | L'oreal | Method and composition for treating skin conditions |
US9918931B2 (en) | 2016-03-31 | 2018-03-20 | L'oreal | Method for providing a customized skin care product to a customer |
MY192213A (en) | 2016-05-23 | 2022-08-08 | Attest Res Sdn Bhd | A composition for preventing or mitigating dementia |
DE102016209964A1 (en) | 2016-06-07 | 2017-12-07 | Henkel Ag & Co. Kgaa | Cold cream containing stable cosmetic cleansing compositions |
US9949915B2 (en) * | 2016-06-10 | 2018-04-24 | Clarity Cosmetics Inc. | Non-comedogenic and non-acnegenic hair and scalp care formulations and method for use |
AU2017280200B2 (en) | 2016-06-24 | 2019-10-03 | Colgate-Palmolive Company | Oral care composition and method of use |
WO2021252292A1 (en) * | 2020-06-08 | 2021-12-16 | Nova Neura, Llc | Systems and methods for treating persistent pain of neurogenic origin and complex injury |
-
2017
- 2017-06-09 US US15/618,420 patent/US9949915B2/en active Active
- 2017-06-09 EP EP17811076.3A patent/EP3468530A4/en active Pending
- 2017-06-09 WO PCT/US2017/036745 patent/WO2017214497A1/en unknown
- 2017-06-09 CA CA3026108A patent/CA3026108A1/en active Pending
- 2017-06-09 JP JP2019516919A patent/JP6992057B2/en active Active
-
2018
- 2018-04-19 US US15/957,238 patent/US10159637B2/en active Active
- 2018-11-15 US US16/192,676 patent/US11160746B2/en active Active
-
2020
- 2020-01-10 US US16/739,774 patent/US10813872B2/en active Active
-
2021
- 2021-10-07 US US17/496,680 patent/US20220079865A1/en active Pending
Patent Citations (59)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5863546A (en) | 1997-03-02 | 1999-01-26 | Swinehart; James M | Cosmetic composition |
EP1077675B1 (en) | 1998-05-12 | 2005-08-24 | InterHealth AB | Compositions for the treatment of acne |
US6406708B1 (en) | 1998-05-12 | 2002-06-18 | Interhealth Ab | Therapeutic compositions |
US7182939B2 (en) | 1998-10-26 | 2007-02-27 | Shiseido Company, Ltd. | Hair tonic composition |
US20030039619A1 (en) | 2000-01-28 | 2003-02-27 | Joachim Bunger | Galenic formulation |
US20070166241A1 (en) | 2000-04-21 | 2007-07-19 | Baker Amy E | Salicylic acid acne spray formulations and methods for treating acne with same |
US6312675B1 (en) | 2000-09-14 | 2001-11-06 | Jeffrey Alan Deane | Hair cleaner |
US20020143063A1 (en) | 2001-01-29 | 2002-10-03 | Alvarado Robert M. | Hair conditioner composition that is non-irritating to the eyes |
US20040186042A1 (en) | 2001-07-09 | 2004-09-23 | Gerhard Schmaus | Iso-$g(b)-bisabolol as fragrance and aroma substance |
US6923954B2 (en) | 2001-08-06 | 2005-08-02 | Kao Corporation | Conditioner |
US7326410B2 (en) | 2001-08-06 | 2008-02-05 | Kao Corporation | Hair conditioner compositions |
US6723309B1 (en) | 2002-06-10 | 2004-04-20 | Jeffrey Alan Deane | Hair cleansing conditioner |
US20040258652A1 (en) | 2003-06-18 | 2004-12-23 | Goldschmidt Ag | Hair treatment compositions and hair after-treatment compositions for protection against damage by chemical treatment and for the repair of already damaged hair comprising as active substances alkylguanidine compounds |
US20040258651A1 (en) | 2003-06-18 | 2004-12-23 | Goldschmidt Ag | Use of alkylguanidine compounds for the treatment and after-treatment of hair |
WO2005018629A1 (en) | 2003-08-12 | 2005-03-03 | Yarbrough William M | Treatment for acne vulgaris and method of use |
US20070082017A1 (en) | 2004-01-10 | 2007-04-12 | Tseng Scheffer C | Lipid compositions and methods of use |
US20060057075A1 (en) | 2004-08-02 | 2006-03-16 | Moshe Arkin | Pharmaceutical and cosmeceutical wash-off mousse shampoo compositions, processes for preparing the same and uses thereof |
EP1693050B1 (en) | 2005-02-02 | 2012-07-11 | Unilever PLC | Care product for skin and/or hair, and the use thereof |
US8173143B2 (en) | 2005-06-02 | 2012-05-08 | Tecco Michelle A | Personal skin care compositions containing anti-flammatory and anti-microbial agents |
US20070286838A1 (en) * | 2006-06-09 | 2007-12-13 | T.F.H. Publications, Inc. | Tamanu Oil Products |
US8957112B2 (en) | 2006-12-21 | 2015-02-17 | Galderma Research & Development | Cream gels comprising at least one retinoid and benzoyl peroxide |
EP2214631B1 (en) | 2007-12-05 | 2013-04-03 | Henkel AG & Co. KGaA | Hair shampoo having a surfactant/thickening combination |
US8092813B1 (en) | 2007-12-28 | 2012-01-10 | Novartis Ag | Polychlorinated biphenyls and squalene-containing adjuvants |
US9370570B2 (en) | 2007-12-28 | 2016-06-21 | Novartis Ag | Polychlorinated biphenyls and squalene-containing adjuvants |
US8628786B2 (en) | 2007-12-28 | 2014-01-14 | Novartis Ag | Polychlorinated biphenyls and squalene-containing adjuvants |
US20090226381A1 (en) | 2008-02-11 | 2009-09-10 | Sarah Maillefer | Method and Composition for Reducing the Drying Time of Hair |
US20080275118A1 (en) | 2008-06-12 | 2008-11-06 | Shaw Mari M | Health and cosmetic composition and regime for stimulating hair growth and thickening on the head, including the scalp, eyelashes, and eyebrows, and which discourages hair loss |
EP2528577B1 (en) | 2009-07-17 | 2018-01-10 | Reckitt Benckiser Healthcare International Limited | Skin care composition for the treatment of acne vulgaris |
US20120189684A1 (en) | 2009-07-17 | 2012-07-26 | Reckitt Benckiser Healthcare International Limited | Skincare Compositions |
US7691792B1 (en) | 2009-09-21 | 2010-04-06 | Amyris Biotechnologies, Inc. | Lubricant compositions |
US8309143B2 (en) | 2010-04-16 | 2012-11-13 | Doreen Campbell | Hair and scalp care formulations for treating and preventing acne and related skin conditions |
US20110256249A1 (en) * | 2010-04-16 | 2011-10-20 | Doreen Campbell | Hair and scalp care formulations for treating and preventing acne and related skin conditions |
US8586814B2 (en) | 2010-05-21 | 2013-11-19 | Amyris, Inc. | Squalane and isosqualane compositions and methods for preparing the same |
US20120082629A1 (en) | 2010-09-01 | 2012-04-05 | Basf Se | Associative Thickeners For Aqueous Preparations |
US20120093755A1 (en) * | 2010-10-15 | 2012-04-19 | Maneworx Inc. | Compositions and methods for treating keratin based fibers |
US20120289590A1 (en) | 2011-05-11 | 2012-11-15 | Gerry Ritterman | Hair cosmetic composition |
US20140154200A1 (en) * | 2011-07-21 | 2014-06-05 | Rhodia Operations | Guar hydroxypropyltrimethylammonium chloride and uses thereof in hair treatment compositions |
US20130090279A1 (en) * | 2011-10-07 | 2013-04-11 | The Procter & Gamble Company | Shampoo Composition Containing a Gel Network |
US20150139929A1 (en) * | 2011-12-22 | 2015-05-21 | Nicholas John Dixon | Personal care composition and method of use thereof |
US9271956B2 (en) | 2012-08-20 | 2016-03-01 | Bionoox Suisse Sa | Companion cosmetic compositions |
US20160008297A1 (en) | 2012-08-23 | 2016-01-14 | B.R.A.I.N. Biotechnology Research And Information Network Ag | Compounds for preventing, reducing and/or alleviating itchy skin condition(s) |
US20140186284A1 (en) | 2012-12-27 | 2014-07-03 | L'oreal | Conditioning compositions for keratinous substrates |
US20140187518A1 (en) | 2012-12-28 | 2014-07-03 | Rak Holdings Llc | Anti-itch scalp treatment compositions and combinations |
WO2014134620A1 (en) | 2013-03-01 | 2014-09-04 | Envy Medical, Inc. | Acne solution |
US20160206573A1 (en) | 2013-03-01 | 2016-07-21 | Envy Medical, Inc. | Anti-Acne Formulation |
US20160374352A1 (en) | 2014-03-10 | 2016-12-29 | The Trustees Of Columbia University In The City Of | Botanical antimicrobial compositions |
WO2015164433A1 (en) | 2014-04-21 | 2015-10-29 | Envy Medical, Inc. | Acne solution |
EP3142633A1 (en) | 2014-05-16 | 2017-03-22 | Restorsea, LLC | Biphasic cosmetic |
WO2015175333A1 (en) | 2014-05-16 | 2015-11-19 | Restorsea, Llc | Biphasic cosmetic |
WO2016012757A1 (en) | 2014-07-22 | 2016-01-28 | Perachem Limited | Hair conditioning compositions |
WO2016018315A1 (en) | 2014-07-30 | 2016-02-04 | Younique, Llc | Formulations, methods and devices for periorbital skin rejuvenation |
EP3174519A1 (en) | 2014-07-30 | 2017-06-07 | Younique, LLC | Formulations, methods and devices for periorbital skin rejuvenation |
EP3191074A1 (en) | 2014-09-12 | 2017-07-19 | The Procter and Gamble Company | Cosmetic compositions and methods for inhibiting melanin synthesis |
US9757317B2 (en) | 2014-09-12 | 2017-09-12 | The Procter & Gamble Company | Cosmetic compositions and methods for inhibiting melanin synthesis |
WO2016040757A1 (en) | 2014-09-12 | 2016-03-17 | The Procter & Gamble Company | Cosmetic compositions and methods for inhibiting melanin synthesis |
WO2017034384A1 (en) | 2015-08-24 | 2017-03-02 | Rīgas Stradiņa Universitāte | Epidermal lipid barrier restoring cream for facial skin, neck and decollete area for metabolic syndrome patients |
US20170096418A1 (en) * | 2015-10-01 | 2017-04-06 | Senomyx, Inc. | Compounds useful as modulators of trpm8 |
WO2017108902A1 (en) | 2015-12-23 | 2017-06-29 | Novartis Ag | Oil-in-water emulsions including retinoic acid |
WO2018000060A1 (en) | 2016-06-30 | 2018-01-04 | L'oreal | Anti-acne sunscreen composition |
Non-Patent Citations (20)
Title |
---|
Alexis C. Perkins, et al., "Acne Vulgaris in Women: Prevalence Across the Life Span," 21 J Womens Health 223-230 (Feb. 2012), URL: http://online.liebertpub.com/toc/jwh/21/2, 9 pgs. |
American Academy of Dermatology, Acne: Overview, https://www.aad.org/public/diseases/acne-and-rosacea/acne visited Jun. 6, 2016, 3 pgs. |
Carly Cardellino, "13 Surprising Reasons You Keep Breaking Out," Cosmopolitan, published May 2, 2016, http://www.cosmopolitan.com/style-beauty/beauty/advice/a32686/surprising-things-that-cause-acne/, 12 pgs. |
Christa Joanna Lee, "How to Get Rid of Forehead Acne," TeenVogue, published Jul. 12, 2016, URL: http://www.teenvogue.com/story/how-to-get-rid-of-forehead-acne, 4 pgs. |
Emil A. Tanghetti, "The Role of Inflammation in the Pathology of Acne," 6 J Clinical and Aesthetic Dermatology, 27-35, Sep. 2013, 9 pgs. |
HerbalLocks.com. "The Top 5 Non-Comedogenic Shampoos." http://www.herballocks.com/natural-shampoos/top-5-non-comedogenic-shampoos/, accessed by examiner on Dec. 22, 2017, 10 printed pages. (Year: 2017). * |
James Q. Del Rosso, et al., "Status Report From the American Acne & Rosacea Society on Medical Management of Acne in Adult Women, Part 1: Overview, Clinical Characteristics, and Laboratory Evaluation," 96(4) Cutis 236-241, Oct. 2015, URL: http://www.cutis.com/uploads/media/media_1b35c69_CT096010236.PDF, 6 pgs. |
Jamese . Fulton, Jr., "Comedogenicity and irritancy of commonly used ingredients in skin care products", j. Soc. Cosmet. Chem., 40, 321-333, Nov./Dec. 1989, 13 pgs. |
Kali Borovic, "12 Hair Mistakes That Cause Acne & Sabotage Your Best Skincare Efforts," Bustle, published Mar. 5, 2016, URL: https://www.bustle.com/articles/146009-12-hair-mistakes-that-cause-acne-sabotage-your-best-skincare-efforts, 17 pgs. |
Kristin Collins Jackson, "3 Paraben and Sulfate Free Shampoos, Serums, and Body Washes to go Natural With This Summer", article in bustle.com (http://www.bustle.com/articles/28720-3-paraben-and-sulfate-free-shampoos-serums-and-body-washes-to-go-natural-with-this-summer), Jun. 20, 2014, 7 pgs. |
L Lanuzo. "Sebamed Everyday Shampoo for Normal to Dry Hair and Scalp." http://www.projectvanity.com/projectvanity/2011/10/27/sebamed-everyday-shampoo-for-normal-to-dry-hair-and-scalp.html, accessed Dec. 22, 2017, originally published Oct. 27, 2011, 8 printed pages. (Year: 2011). * |
Lauren Valenti, "The Sneaky Thing Thats Making You Break Out . . . All Over," MarieClaire, published Mar. 10, 2016, http://www.marieclaire.com/beauty/news/a19207/hair-products-skin-breakouts/, 8 pgs. |
Lexy Lebsack, "The Annoying Reason You May Be Breaking Out," Refinery29, published Jan. 9, 2016, URL: http://www.refinery29.com/hair-products-skin-break-outs, 16 pgs. |
Lily Talakoub, "Smooth hair-an acne-causing epidemic," Dermatology News, published Apr. 19, 2016, URL: http://www.mdedge.com/edermatologynews/article/108161/acne/smooth-hair-acne-causing-epidemic, 4 pgs. |
Lily Talakoub, "Smooth hair—an acne-causing epidemic," Dermatology News, published Apr. 19, 2016, URL: http://www.mdedge.com/edermatologynews/article/108161/acne/smooth-hair-acne-causing-epidemic, 4 pgs. |
Nancy Janiczek-Dolphin, et al., "Can sebum reduction predict acne outcome?" 163(4) Br J Dermatol 683-8, Oct. 2010, URL: http//www.medscape.com/viewarticle/730258, 10 pgs. |
Notification of Transmittal of the International Search Report and the Written Opinion of the International Searching Authority dated Sep. 12, 2017, in connection with corresponding international application No. PCT/US2017/036745 (12 pgs.). |
Porespective, "Five Causes of Adult Acne That May Surprise You," Porespective, printed May 15, 2017, URL: https://www.porespective.com/five-causes-of-adult-acne-that-may-surprise-you/, 8 pgs. |
Tina Ferraro, "Is Your Conditioner Causing You to Break Out?," TeenVogue, published Jul. 3, 2015, URL: http://www.teenvogue.com/story/hair-conditioner-causing-acne-breakouts, 4 pgs. |
Valerie Tejeda, "Are Your Hair Products Making You Break Out?," TeenVogue, published Jul. 21, 2014, http://www.teenvogue.com/story/hair-products-cause-acne, 4 pgs. |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10813872B2 (en) * | 2016-06-10 | 2020-10-27 | Clarity Cosmetics Inc. | Hair and scalp formulations |
US11160746B2 (en) * | 2016-06-10 | 2021-11-02 | Clarity Cosmetics Inc. | Non-comedogenic and non-acnegenic hair and scalp care formulations and method for use |
US20220079865A1 (en) * | 2016-06-10 | 2022-03-17 | Clarity Cosmetics Inc. | Non-comedogenic and non-acnegenic hair and scalp care formulations and method for use |
US11975087B2 (en) | 2020-03-30 | 2024-05-07 | Colgate-Palmolive Company | Sulfate-free personal care compositions and methods for preventing and treating pollution damage to skin |
Also Published As
Publication number | Publication date |
---|---|
EP3468530A4 (en) | 2020-03-11 |
US20180235865A1 (en) | 2018-08-23 |
US10813872B2 (en) | 2020-10-27 |
US20170354585A1 (en) | 2017-12-14 |
US10159637B2 (en) | 2018-12-25 |
WO2017214497A1 (en) | 2017-12-14 |
US20220079865A1 (en) | 2022-03-17 |
US20190183775A1 (en) | 2019-06-20 |
JP6992057B2 (en) | 2022-01-13 |
US20200146964A1 (en) | 2020-05-14 |
EP3468530A1 (en) | 2019-04-17 |
JP2019517592A (en) | 2019-06-24 |
US11160746B2 (en) | 2021-11-02 |
CA3026108A1 (en) | 2017-12-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US10813872B2 (en) | Hair and scalp formulations | |
CN108366935B (en) | Pet care cleansing compositions | |
BR112021015345A2 (en) | ACTIVE AGENTS FOR SKIN AND HAIR CARE WITH SENSORY MODIFYING PROPERTIES | |
JP2002226386A (en) | Composition for integument containing plant extract | |
JP6062538B2 (en) | Compositions that provide shine and methods of use | |
CN111936130B (en) | Topical preparations and treatments containing strontium and methylsulfonylmethane (MSM) | |
US6977081B1 (en) | Facial cream composition containing allantoin | |
JPH11269043A (en) | Cosmetic for scalp and hair | |
US12097280B2 (en) | Personal care compositions and methods for the same | |
RU2722823C2 (en) | Cosmetic composition for treating and preventing acne on skin | |
JPS6322510A (en) | External preparation for skin | |
JPH11302147A (en) | Cosmetic | |
KR20040056079A (en) | Cosmetic composition for preventing and therapeutic for a pimple | |
EP2346485B1 (en) | Use of betaine | |
KR100242858B1 (en) | Hair shampoo composition for the treatment of itching or dandruff | |
JPH083042A (en) | Antidandruff agent | |
KR20160068294A (en) | Composition containing panasenoside for antibacterial | |
JP4327989B2 (en) | Hair cosmetics | |
JP2005325091A (en) | External preparation composition | |
GB2205743A (en) | Cosmetic composition for prevention and/or treatment of dandruff | |
JPS62169717A (en) | Hair cosmetic | |
Chester | Afro products | |
KR20160066171A (en) | Composition containing icariside B2 for antibacterial | |
KR20160064705A (en) | Composition containing icariside B6 for antibacterial | |
JPS6322507A (en) | External preparation for skin |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: CLARITY COSMETICS, LLC, MARYLAND Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:RUBIN, IRIS;MAGED, GREGORY;GARRUTO, JOHN;AND OTHERS;REEL/FRAME:042716/0521 Effective date: 20170608 |
|
AS | Assignment |
Owner name: CLARITY COSMETICS INC., MARYLAND Free format text: CHANGE OF NAME;ASSIGNOR:CLARITY COSMETICS, LLC;REEL/FRAME:043257/0218 Effective date: 20160929 |
|
STCF | Information on status: patent grant |
Free format text: PATENTED CASE |
|
CC | Certificate of correction | ||
MAFP | Maintenance fee payment |
Free format text: PAYMENT OF MAINTENANCE FEE, 4TH YR, SMALL ENTITY (ORIGINAL EVENT CODE: M2551); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY Year of fee payment: 4 |